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1. INTRODUCTION 
1.1. Lipid signaling – a historical review 
Lipids, naturally occurring hydrophobic or amphiphilic molecules, fulfill three general 
functions in living cells: energy storage, being structural components of cellular 
membranes, and being important signaling molecules. Although the first two roles have 
long been well described, the concept of ‘bioactive lipids’ became well established only in 
the past 20 years. Since then, the theme of lipid signaling has grown to occupy center-
stage in molecular and cell biology research. Lipids participate in such wide-ranging 
cellular processes like growth, differentiation, apoptosis, senescence, adhesion, migration, 
inflammation, angiogenesis and intracellular trafficking. Members of several different 
lipid categories, including sphingolipids, diacylglycerol, phosphatidylinositol phosphates, 
prostaglandins and steroid hormones, have been identified as cellular messengers, 
mediating specific molecular recognition processes and signal transduction pathways. In 
addition, some lipids function to define membrane domains (rafts), which recruit proteins 
from the cytosol that subsequently organize secondary signaling or effector complexes. 
In the 1960s arachidonic acid was identified as the source of leukotrienes and 
prostaglandins, a discovery that has led to our current understanding of eicosanoid 
signaling, and taught us that the same signaling lipid can provoke different cellular 
responses, depending on the cell type. The study of the lipid components of cellular 
membranes, and in particular the turnover of phosphoinositides, culminated in the 1980s 
with the discovery that phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) could be 
hydrolyzed by phospholipase C (PLC) to diacylglycerol (DAG) and inositol-1,4,5-tris-
phosphate (Ins(1,4,5)P3). Both products were identified as second messengers that trigger 
the activation of protein kinase C (PKC) and the release of Ca2+ from internal stores, 
respectively. In parallel, inositol and phosphoinositide kinases have been identified; these 
enzymes generate a huge repertoire of soluble inositol polyphosphates and membrane 
polyphosphoinositide lipids. Phosphoinositide 3-kinase (PI3K), for example, which is 
regulated by cell-surface receptors, promotes the formation of phosphatidylinositol-3,4,5-
trisphosphate (PtdIns(3,4,5)P3), a signaling lipid that modulates cell growth, proliferation 
and motility. Interestingly, nature has used several possible variations of the inositol head 
group to create highly specific docking sites for lipid-binding proteins, effector proteins 
that trigger signaling cascades or enzymes that further modify these lipids (see next 
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chapter). Phosphoinositides have, therefore, gained importance as localization tags that are 
involved in the organization of membrane-bound signaling complexes [1-3]. 
Two groups that most recently gained attention are sphingolipids (derivatives of 
the sphingoid base) [4-8] and lysophospholipids (phospholipids with only one fatty acid 
chain) [9-11]. Ceramides and sphingosines have pro-apoptotic and antiproliferative 
actions; when phosphorylated by lipid kinases, however, sphingosine is converted into 
sphingosine-1-phosphate (S1P), which promotes cell growth and proliferation by a still 
poorly understood intracellular action as well as by extracellular signaling through a set of 
different G protein-coupled receptors (GPCRs). Another lipid that is released from cells, 
lysophosphatidic acid (LPA), also functions in an autocrine and paracrine manner by 
binding to a family of GPCRs. LPA, together with specific eicosanoids, can additionally 
modulate gene expression by binding to lipid-sensing transcription activators, such as the 
peroxisome proliferator-activated receptors (PPARs). 
With this brief introduction to the most widely studied lipid mediators, I aimed to 
demonstrate the diversity of the lipid signaling field. For a more detailed review of the 
current ‘hot topics’ in the area please refer to the 2008 special lipid edition of Nature 
Reviews Molecular Cell Biology [12-17]. From now on, I will only focus on those aspects 
of lipid signaling that are essential for the comprehension of this thesis. 
 
1.2. Basic concepts of lipid-protein interactions 
Lipid-protein interactions drive core cellular signaling events and regulate the function of 
most membrane proteins. A wide variety of globular phospholipid-binding domains exist, 
and many have been extensively characterized (Table 1). 
The interactions of these domains with the membrane surface fall into two broad 
classes. Some are highly specific and involve stereoselective recognition of particular 
lipids. The most specific cases involve domains that selectively recognize rare membrane 
components that are restricted in their location, time of synthesis or both. Among 
phospholipids, the phosphoinositides represent the best examples of acutely regulated 
binding targets, and all phosphoinositides except PtdIns4P and PtdIns5P have one or more 
well characterized specific binding domains. Figure 1 depicts the structures of the most 
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Figure 1 Structures of target-specific phospholipid-binding domains. Domains depicted are 
from left to right: the protein kinase C  (PKC ) C1 domain (PDB code 1PTR), the phospholipase 
C 1 (PLC 1) PH domain (PDB code 1MAI), the p40phox PX domain (PDB code 1H6H), the early 
endosome antigen-1 (EEA1)41 FYVE domain dimer (PDB code 1JOC), the ARHGAP9 PH 
domain (PDB code 2P0D) and the p47phox PX domain (PDB code 1O7K). Figure taken from 
[12]. 
 
Other lipid-binding domains are non-specific and involve attraction to a general 
physical property of the membrane, such as charge, amphiphilicity and curvature. For 
these membrane-binding domains, the physiological target is an abundant phospholipid 
that is ubiquitous in cell membranes. For example, several phospholipid-binding domains, 
including C2 domains and annexins, interact with phosphatidylserine, while many 
phosphoinositide-binding domains bind similarly to all of the polyphosphoinositides. 
Domains with these non-specific characteristics do not simply bind persistently to any 
membrane that contains phosphatidylserine or polyphosphoinositides. Rather, some of 
them (such as certain C2 domains and annexins) bind phospholipids only when cytosolic 
calcium levels are transiently elevated. Others, such as BAR and F-BAR domains, seem to 
interact only with highly curved regions of membranes. These mechanisms allow temporal 
and spatial specificity in membrane targeting without changing the nature of the 
headgroup itself. 
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These domains have taught us a lot about the mechanistic details of lipid 
recognition processes involved in cellular signaling. Nevertheless, those interactions that 
are not established by these specific lipid-binding globular domains, rather by proteins 
which do not hold a well-defined lipid-binding site, are yet not well described [18, 19]. 
These interactions are often manifested between a cluster of lipids and the protein, and 
cannot be characterized by a simple binding model. The change in the micellar or 
liposomal state (Figure 2) of the lipid under different experimental conditions often 
complicates evaluation of such data. The biological significance of understanding the 
mechanism of these interactions is outstanding, but due to technical difficulties they are 
rarely characterized at a structural molecular level. I hope that later on I will convince the 
reader that my work provides significant new insights into this emerging field. 
 
 
Figure 2 Clustering of lipids in an aqueous environment. Bilayer-forming phospholipids 
(shown in red), such as phosphatidylcholine (PC), can be approximated as rods. Micelle-forming 
lysophospholipids (blue), such as lysophosphatidylcholine (LPC) with only one fatty acid chain, 
can be regarded as cones. 
 
1.3. Biological functions, occurrence and metabolism of 
sphingosylphosphorylcholine 
Sphingosylphosphorylcholine (lysosphingomyelin, SPC) belongs to a group of structurally 
related lysophospholipids, such as sphingosine-1-phosphate (S1P), 
lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA) (Figure 3), which serve 
as potent and versatile lipid mediators in a large variety of cell types. The topic of my 
thesis is the characterization of a newly identified interaction between SPC and 
calmodulin (CaM); therefore, here I present SPC’s biology in detail. 
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Figure 3 Lysophospholipids with important roles in cellular signaling. 
 
In lipid signaling, two major principles can be found: cellular release or 
extracellular formation of a lipid species, which then activate specific plasma membrane 
receptors, mostly in an autocrine or paracrine manner, or stimulus-induced intracellular 
formation of such lipids, which then serve as intracellular mediators of the physiological 
reactions to the stimulus. S1P and SPC have the quaint property of being able to exert both 
actions (Figure 4). While the biology of S1P is extensively studied [20], less information 
is available regarding the mechanism of action and metabolism of SPC. For extensive 
reviews on SPC’s biological functions see [21, 22]. 
SPC first attracted attention as a remarkably potent mitogen for a variety of cell 
types [23]. Since then, extracellularly applied SPC has been shown to cause rapid 
increases in intracellular Ca2+ concentration in a number of cell lines [24-30], to induce 
stress fiber formation and other cytoskeleton rearrangements [31], to activate potassium 
currents in atrial myocytes [32] and to modulate cell migration [33]. These findings 
demonstrate that SPC is a potentially important regulator of cell type specific functions in 
major tissues, such as the heart, blood vessels, skin, brain and the immune system. Some 
of these actions can be explained by low-affinity binding to S1P-receptors, while certain 
effects are not shared by S1P, suggesting that SPC is a lipid mediator on its own right. 
After the discovery of specific cell surface G-protein-coupled receptors for SPC, as 
ovarian cancer G-protein-coupled receptor 1 (OGR1) [34] and GPR4 [35], much attention 
was dedicated to its first messenger functions. However, these two papers have been 
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retracted, and recent studies have shown that these receptors are rather proton sensors 
[36], leading to debate in the field. Although the majority of publications focus on the 
effects of extracellularly applied SPC, the sphingolipid has intracellular messenger 
functions as well, mediating the release of Ca2+ from internal stores, described in details in 
the following chapter. 
 
Figure 4 Extra and intracellular roles of SPC and S1P. As first messengers, SPC and S1P 
activate cell-surface G protein-coupled receptors in a well-described manner, triggering 
intracellular signaling pathways that can lead to elevation of intracellular IP3 levels and 
mobilization of Ca2+ from the ER. As second messengers, their intracellular levels rise upon 
extracellular stimuli, also leading to Ca2+ liberation from the ER, however, in a yet unknown 
manner. 
 
Albeit data on SPC metabolism is yet scarce, its presence has been demonstrated 
under several physiologic and pathologic conditions. SPC has been found in ascitic fluids 
[37]; where its levels were similar to those of S1P (~100 nM), but much lower than those 
of LPA (~20 μM). In ascites caused by ovarian cancer, levels of SPC were significantly 
higher than in non-malignant ascites, suggesting that SPC may have a pathophysiological 
role. Furthermore, SPC was detected in normal rabbit plasma and serum [38]. SPC levels 
in the serum were slightly higher than in the plasma, suggesting that SPC, like S1P and 
LPA, is formed during blood clotting. SPC, together with other bioactive lipids, was found 
to be associated with high-density lipoproteins (HDL) compared to low-density 
lipoproteins (LDL), and it was proposed that SPC represents one of the anti-atherogenic 
activities of HDL [39]. Moreover, the metabolism of SPC has been detected to be very 
rapid in the circulation [38] and the average concentration of the lipid in cardiac muscle 
has been estimated to be as high as 15.6 M [40]. These findings strongly suggest that the 
sphingolipid plays an important role in the cardiovascular system. 
 11 
SPC accumulates in Niemann–Pick disease, which is characterized by deficiency 
of acid sphingomyelinase [41]. Acid sphingomyelinase deficiency primarily leads to 
accumulation of sphingomyelin; the mechanism for the observed increase in SPC is 
presently not known. SPC levels were highly elevated in the brain, liver and spleen of 
Niemann–Pick disease type A patients. In type B patients, SPC was likewise elevated in 
liver and spleen, but normal in the brain. Therefore, a contribution of SPC to brain 
dysfunction, which is found in type A but not B, was postulated. In patients suffering from 
atopic dermatitis, the activity of sphingomyelin deacylase was enhanced, which appears to 
accumulate SPC and deplete sphingomyelin, so that ceramide formation by 
sphingomyelinase is decreased [42]. 
 
Figure 5 Potential pathways of sphingosylphosphorylcholine metabolism. Figure taken from 
[22]. 
 
Unfortunately, the pathways of physiological SPC production are yet unknown. 
Earlier work suggested the formation of SPC from sphingosine and CDP-choline [43]; 
however, the specific enzyme responsible for such an activity has not been identified yet. 
Alternatively, SPC may be formed by sphingomyelin deacylase, an enzyme that was 
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partially purified from the skin of atopic dermatitis patients [44]. In cardiac myocytes SPC 
production was significantly increased by incubation with the endothelial-derived peptide, 
endothelin-1 [45]. This was found to occur via breakdown of sphingomyelin, but not via 
sphingosine, also suggesting the involvement of sphingomyelin deacylase. The pathways 
of SPC degradation are even less well understood. Exogenous SPC injected in vivo into 
the blood is undetectable within a single pass through the coronary circulation suggesting 
that it is rapidly metabolized [38]. One possible enzyme that may be involved is autotaxin, 
an exoenzyme that has lysophospholipase D activity and has been implicated in regulation 
of tumor cell migration [46]. Nevertheless, autotaxin is a secreted enzyme, and as such, 
would only be able to clear extracellularly localized SPC. For an overview of SPC’s 
supposed place in sphingolipid metabolism refer to Figure 5. It is important to note that 
our scant knowledge in the field can largely be attributed to the lack of a thorough analysis 
of SPC metabolism. Compared to the intensively studied S1P and ceramide, only weak 
efforts have been made to decipher SPC occurrence and metabolism in cells. I hope that 
the results presented in this thesis, which suggest a specific intracellular target for SPC, 
will encourage research in the field. 
 
1.4. Sphingosylphosphorylcholine and Ca2+ signaling 
As mentioned in the previous section, SPC has the unique feature of being capable to 
mobilize Ca2+ from internal stores acting both extracellularly through G protein-coupled 
receptors and intracellularly in a yet undefined manner [47, 48]. Although there is a 
certain level of confusion in the literature, it is important to differentiate between these 
two modes of action. SPC’s effect on intact, but not in permeabilized cells, was shown to 
be sensitive to pertussis toxins, indicating the involvement of GPCRs. In addition, Ca2+ 
release in permeabilized cells was not stereoselective, whereas in intact cells only the 
naturally occurring D-erythro-SPC, but not L-threo-SPC triggered Ca2+ influx [49]. Ghosh 
et al. were the first to report on the intracellular Ca2+ release mediating ability of 
sphingosine derivatives [50, 51]. These studies revealed that SPC immediately liberates 
Ca2+ from permeabilized smooth muscle cells with an EC50 of 2.8 μM. Sphingosine 
exerted a similar action, but had a lag phase, implying that it first has to be enzymatically 
converted to S1P. 
Since these first reports, two main proposals have been made on the intracellular 
target sites for SPC. The involvement of a novel intracellular sphingolipid-gated Ca2+-
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permeable channel from rat basophilic leukemia [52] and endothelial [53] cells has been 
suggested. The channel has been cloned and named SCaMPER, sphingolipid Ca2+ release 
mediating protein from endoplasmic reticulum [54]. However, in a subsequent study 
Schnurbus et al. demonstrated that SCaMPER is unlikely to be a Ca2+ channel, as it 
contains only one membrane-spanning region [55]. 
Another suggestion was that SPC regulates the activity of ryanodine receptors 
(RyRs), Ca2+ channels of the endoplasmic reticulum. These receptors were proposed to 
play a role in SPC-induced Ca2+ release from brain microsomes [56, 57] and from cardiac 
sarcoplasmic reticulum membranes [40]. RyRs are huge channel complexes composed of 
tetramers of 560 kDa monomers. Among the three isoforms RyR1 is expressed primarily 
in skeletal muscle, RyR2 is the dominant isoform in cardiac muscle, and RyR3 is found in 
a wide variety of tissues. They display a characteristic bell-shaped, biphasic dependence 
on cytosolic Ca2+ concentration with micromolar Ca2+causing channel activation and 
elevated Ca2+ concentrations resulting in channel inhibition. Besides Ca2+, these receptors 
are regulated by several small molecules and proteins (Figure 6) including the ubiquitous 
Ca2+ sensor calmodulin (CaM) [58]. Regulation of RyRs by CaM is complex, but the 
sensor clearly plays a role in the negative feedback of the Ca2+ signal, through inhibition 
of channel activity by Ca2+CaM [59, 60]. In contrast to reports on the activation of RyRs 
by SPC, Uehara et al. demonstrated that the open probability of cardiac RyR ion channels 
decreases on application of SPC [61, 62]; hence, the question of SPC's intracellular 
mechanism of action is still open. 
 
 
Figure 6 Regulation of RyRs. Channel opening is triggered by Ca2+ ions or the dihydropyridin 




1.5. Overview of Ca2+ signaling 
Ca2+ is a highly versatile second messenger regulating numerous cellular functions. 
Resting intracellular Ca2+ concentrations (~100 nM) can be elevated to low micromolar 
levels through several pathways to create Ca2+ signaling systems with different spatial and 
temporal properties. Importantly, the Ca2+ signal should not be thought of as an on or off 
response. Rapid, highly localized Ca2+ spikes regulate fast responses, whereas slower 
responses are controlled by repetitive global Ca2+ transients or intracellular Ca2+ waves. 
 
Figure 7 Calcium-signaling dynamics and homeostasis. During the ‘on’ reactions, stimuli 
induce both the entry of external Ca2+ and the formation of second messengers that release internal 
Ca2+ that is stored within the endoplasmic/sarcoplasmic reticulum (ER/SR). Most of this Ca2+ 
(shown as red circles) is bound to buffers, whereas a small proportion binds to the effectors that 
activate various cellular processes that operate over a wide temporal spectrum. During the ‘off’ 
reactions, Ca2+ leaves the effectors and buffers and is removed from the cell by various exchangers 
and pumps. The Na+/Ca2+ exchanger (NCX) and the plasma membrane Ca2+-ATPase (PMCA) 
extrude Ca2+ to the outside, whereas the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 
pumps Ca2+ back into the ER. Mitochondria also have an active function during the recovery 
process in that they sequester Ca2+ rapidly through a uniporter, and this is then released more 
slowly back into the cytosol to be dealt with by the SERCA and the PMCA. Cell survival is 
dependent on Ca2+ homeostasis, whereby the Ca2+ fluxes during the off reactions exactly match 
those during the on reactions. Figure imported from [63]. 
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The Ca2+ signal can either be derived from the extracellular medium or from 
internal stores. Plasma membrane channels such as voltage operated channels and 
transient receptor potential channels respond to membrane depolarization, while receptor-
operated channels including N-methyl-D-aspartic acid (NMDA), adenosine-triphosphate 
(ATP) and nicotinic acetylcholine (nACh) receptors respond to extracellular agonists. The 
release of Ca2+ from the endoplasmic reticulum (ER) or its muscle equivalent, the 
sarcoplasmic reticulum (SR) is mediated by Ca2+ itself in case of RyRs or by an expanding 
group of second messengers including inositol-1,4,5-triphosphate (IP3Rs), cyclic ADP 
ribose (cADPR), nicotinic acid adenine dinucleotide phosphate (NAADP) and 




Figure 8 Maintaining and using Ca2+ gradients for signaling. (A) The cytoplasmic Ca2+ level is 
low in resting cells. Cytoplasmic [Ca2+] is maintained at ~100 nM by extrusion via plasma 
membrane Ca2+ ATPase (PMCA) and smooth endoplasmic reticular Ca2+ ATPase (SERCA) 
transporters. The Na+/Ca2+ exchanger (NCX), a major secondary regulator of [Ca2+], is 
electrogenic, exchanging three Na+ ions for one Ca2+. Intracellular Ca2+ hyperpolarizes many cells 
by activating K+ channels, and in some cells, Cl  channels. This decreases CaV channel activity 
but increases the driving force across active Ca2+-permeant channels. (B) The core of the Ca2+ 
signaling network. In excitatory Ca2+ signaling, plasma membrane ion channels are triggered to 
open by changes in voltage, or extra- or intracellular ligand binding. When open, ~1 million Ca2+ 
ions/s/channel flow down the 20,000 fold [Ca2+]i gradient (ECa ~ +150 mV), maintained by 
elements shown in (A). Initial increases in [Ca2+] trigger more release, primarily from ER via Ca2+-
sensitive ryanodine receptors (RyR). G protein-coupled receptor (GPCR) or receptor tyrosine 
kinase (RTK) mediated activation of phospholipase C (PLC) cleaves PIP2 into inositol (1,4,5) 
trisphosphate (IP3) and diacylglycerol (DAG). IP3 is a ligand for the intracellular IP3R channel 
spanning the membrane of the ER. GPCRs catalyze the exchange of guanosine diphosphate (GDP) 
for GTP on G  subunits, releasing active G  and G  subunits that in turn activate PLC . RTKs 
dimerize upon ligand binding, autophosphorylate, and interact with other signaling proteins to 
activate PLC . Figure imported from [65]. 
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In the next step of the pathway, the signal is relayed to proteins containing Ca2+-
binding motifs, most importantly EF-hands and C2 domains. Among them, Ca2+ buffers 
fine-tune the signal, while Ca2+-sensor proteins act as effectors regulating multiple other 
proteins. The result of this activating process might be a wide variety of physiologic 
cellular responses, most notably exocytosis, contraction, metabolism, transcription, 
fertilization and proliferation. 
Finally, to remove excess Ca2+ from the cytosol, the effect of channels is 
counteracted by pumps, the plasma membrane Ca2+ ATPase (PMCA) and the 
sarcoendoplasmic reticulum Ca2+ pump (SERCA) and exchangers, the Na+/Ca2+ 
exchanger (NCX). Besides switching of the Ca2+ signal, these membrane proteins play an 
important role in maintaining resting Ca2+ levels. Various aspects of the signaling process 
are highlighted in Figure 7 and 8, for recent reviews see [63-65]. 
 
1.6. Calmodulin, the ubiquitous Ca2+ sensor 
In the hub of Ca2+ signaling events lies calmodulin (CaM), the ubiquitous Ca2+ sensor of 
eukaryotic cells [66]. CaM is a small (148 residues), acidic (pI = 4.1), soluble, dumbbell-
shaped, evolutionarily highly conserved protein. 
 
 
Figure 9 Basics of CaM function. (A) Structure of Ca2+-saturated CaM. (B) Classical mode of 
CaM action. 1) CaM binds 4 Ca2+ ions. 2) CaM changes conformation resulting in an active 
complex 3) The two globular “hands” of the complex wrap around a binding site on a target 
protein. Figure adapted from Principles of Cell Biology, Pearson Education Inc. 
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The Ca2+ binding motifs of CaM are four EF-hand structures, which consist of an 
N-terminal helix (the E helix), followed by a centrally located Ca2+-coordinating loop and 
a C-terminal helix (the F helix), resembling a thumb, index and middle fingers of a hand, 
hence the name EF-hand. The first two EF-hands combine to form a globular N-terminal 
domain that is separated by a short flexible linker from a homologous C-terminal domain 
consisting of the other two EF-hands (Figure 9A). CaM is the most prominent member of 
Ca2+-sensor proteins, including the structurally similar troponin C and S100 proteins, that 
all undergo a conformational change upon binding to Ca2+. 
The mechanism of CaM function and target binding is versatile (see below), but in 
the most common scenario (Figure 9B) the structural rearrangements upon Ca2+-binding 
result in the exposure of hydrophobic groups in a methionine-rich crevice of each domain, 
allowing CaM to interact with a wide variety of target proteins. The Ca2+-sensor wraps 
around the CaM binding domain of target proteins, which are structurally ~20 residue-
long basic amphipatic -helices. The ensuing structural reorganization in the effector 
protein most often leads to its activation by release of autoinhibition. Other, less generic 




Figure 10 Ribbon presentations of CaM and CaM in complex with target peptides. CaM is 
colored blue, the CaM targets are red, Ca2+ ions are yellow. The N-terminal lobe of CaM is 
orientated to the top, the C-terminal lobe to the bottom of the figures. Structural data were taken 
from the Protein Data Bank, accession codes: apo-CaM (1CFD); Ca2+/CaM (1CLL); 
CaM/CaMKIIa (1CM1); CaM/CaMKK (1IQ5); CaM/Ca2+-pump (1CFF); CaM/K+-channel 
(1G4Y), CaM/anthrax exotoxin (1K93). Figure taken from [68]. 
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 The list of CaM targets is vast and constantly growing. The most extensively 
characterized effectors and their physiological functions are listed in Table 2.  
 
Table 2 Prominent examples of CaM-regulated proteins. 
Protein Function Ref. 
Adenylate cyclase cAMP generation [69] 
Phosphodiesterase cAMP degradation [70] 
CaM kinase I Neurotransmission, transcription regulation [71] 
CaM kinase II Involvement in long-term potentiation, memory [72] 
CaM kinase IV Transcription regulation [71] 
CaM kinase kinase Regulation of CaM kinase I/IV [71] 
Myosin light chain 
kinase 
Regulation of muscle contraction [73] 
Calcineurin Phosphatase, essential role in transcription regulation [74] 
Plasma membrane Ca2+ 
pump 
Ca2+ pump of the PM [75] 
Ryanodine receptor Ca2+ channel of the ER [59] 
IP3 receptor Ca
2+ channel of the ER [76] 
 
Based on their modes of regulation, CaM-dependent proteins can be categorized 
into six main classes (Figure 11). Class A effectors bind essentially irreversibly to CaM 
irrespective of Ca2+, thus, the Ca2+-sensor can be considered as a subunit of these proteins, 
for example phosphorylase kinase. Nevertheless, Ca2+ is required for their activation. 
Class B effectors bind to CaM only in the absence of Ca2+. Examples include 
neuromodulin and neurogranin, proteins which might serve as intracellular reservoirs for 
CaM at resting Ca2+ concentrations. Class C targets form low affinity, inactive complexes 
with CaM at low Ca2+ concentrations, and engage in a high-affinity, active complex upon 
increase of intracellular [Ca2+]. Smooth muscle myosin light chain kinase and calcineurin 
behave in this manner. Class D proteins, such as select members of the G-protein-receptor 
kinases and the IP3R1, bind to CaM in the presence of Ca
2+, but are inhibited by the Ca2+-
sensor. Class E targets, such as CaM-dependent protein kinases I, II and IV, exhibit 
behavior considered to be more conventional and are activated by Ca2+CaM. Some class E 
effectors are additionally regulated by another CaM regulated kinase (CaM kinase kinase), 
which is designated class F. 
With these examples I wished to demonstrate the versatility of CaM action, in the 
light of which we can appreciate the potential of the CaM-SPC interaction, the topic of 
this thesis, to provide an utterly novel means of interfering with CaM function. Uniquely, 
SPC binds not only to Ca2+CaM but also to the apo protein, while classical synthetic CaM 
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inhibitors bind only in the presence of Ca2+. Removing both forms of the protein from 
these targets could result in yet unprecedented regulatory effects. 
 
 
Figure 11 Ca2+-dependent functions of various classes of CaM-binding proteins. Target 
classes A, B and C are associated with CaM or Ca2+-free CaM at low (resting) intracellular free 
Ca2+ concentrations (red). When Ca2+ concentrations are high (green), class B dissociates from 
CaM, classes D, E and F associate with CaM, classes A, C, E and F are activated by CaM, and 
class D is inactivated by CaM. Figure taken from [66]. 
 
The intracellular abundance of CaM (0.1% of total protein) and the large array of 
its targets lead to the so-called ubiquitous CaM paradox [77]. How can CaM interact with 
specific targets in a temporally and spatially regulated manner? This question is most 
apparent in cases when the Ca2+-sensor regulates reactions of opposing effects, such as the 
synthesis and degradation of cAMP by adenylate cyclase and phosphodiesterase, 
respectively or the phosphorylation and dephosphorylation of proteins by kinases and 
phosphatases. Several suggestions have been made to solve the apparent paradox, the 
basic concept of each being that CaM and CaM-dependent activity is highly regulated in 
space and time, achieved either by differential gene expression, variation in localization or 
post-transcriptional modification [77-79]. 
I wish to point out that inhibition of CaM function by SPC, described in my thesis 
in detail, has the potential to significantly contribute to local CaM regulation in living 
cells, providing another, alternative explanation for the CaM paradox. Our finding 
conceptually differs from previous suggestions however, as we propose that CaM activity 
is transiently modified by an endogenous lipid mediator. So far, apart from Ca2+, no other 
second messenger has been shown to directly regulate CaM activity. The pharmacologic 
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inhibitors of CaM, such as trifluoperazine, calmidazolium and W7 [80-82], are all 
synthetic aromatic molecules. There are reports on natural compounds presenting anti-
CaM activity [83], but these substances can only be found in certain plant species and 
animal venoms, and neither can be found in humans. SPC, on the other hand, has been 
detected under several physiological and pathological conditions in human and 




• My primary goal was to gain information about the intracellular mechanism of 
action of S1P and SPC, sphingolipids involved in Ca2+ signaling as putative second 
messengers. 
 
• Our approach was to identify a protein that interacts specifically with these 
sphingolipids. Our candidate for an intracellular target was CaM. 
 
• After demonstrating that SPC is a specific inhibitor of CaM in in vitro enzyme 
assays, my aims became more definite. 
 
• I concentrated on the characterization of the newly identified CaM-SPC 
interaction, which potentially has important consequences in both Ca2+ and lipid 
signaling. 
 
• My goals were to give an in-depth structural analysis of the interaction and 
mechanistic insight into the binding process. 
 
• I aimed to set up a detailed model that explains the basis of competitive inhibition 
witnessed in enzymatic assays. 
 
• I wanted to reveal the functional consequences of the CaM-SPC interaction, 
focusing on proteins involved in Ca2+ homeostasis, especially RyRs. 
 
• The ultimate goal of deciphering the in vivo relevance and significance of the newly 
identified interaction exceeds the scope of this thesis and remains for the future. 
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3. MATERIALS AND METHODS 
 
3.1. Lipids 
D-erythro-sphingosylphosphorylcholine (SPC, cat. no. 860600), D-erythro-sphingosine-1-
phosphate (S1P, cat. no. 860492), oleoyl-lysophosphatidylcholine (LPC, cat. no. 845875) 
and oleoyl-lysophosphatidic acid (LPA, cat. no. 857130) was purchased from Avanti Polar 
Lipids. L-threo-sphingosylphosphorylcholine (LT-SPC, cat. no. 1319) was from Matreya. 
Lipids were delivered from 10 mM methanolic stock solutions. 
Please note that the ‘Materials and Methods’ section includes solely the 
information required to repeat the experiments. Rationale, explanations and comments 
regarding why and how these methods were applied can be found in the relevant sections 
of ‘Results’. 
 
3.2. Preparation of CaM from bovine brain 
CaM was purified from bovine brain using isoelectric precipitation and phenyl-sepharose 
(Amersham Biosciences, 17-0973-05) affinity chromatography according to 
Gopalakrishna and Anderson [84]. Protein purity was checked by SDS-PAGE, and CaM 
concentration was determined by circular dichroism spectroscopy (molar residual 
ellipticity of 158 000 deg cm2 at 222 nm [80]). 
 
3.3. Intrinsic tyrosine fluorescence 
Spectra were collected using a Jobin Yvon Fluoromax-3 spectrofluorimeter at 25°C in 10 
mM HEPES, pH 7.4, 100 mM KCl, and 1 mM EGTA or CaCl2. Bandwidths were adjusted 
to 5 nm, Tyr was excited at 274 nm, emission was monitored from 285 to 370 nm, and 
values were read at 303 nm. Protein and lipid concentrations were 1 M and 100 M, 
respectively. Buffer containing lipids was measured as a blank. After the addition of CaM, 
the spectrum was scanned again and corrected by subtracting the blank. 
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3.4. Fluorescence of dansyl-labeled CaM 
CaM was dansylated by reacting 1 mg of protein with 5 fold molar excess of dansyl-
chloride (Fluka, 39220) in 1 ml 10 mM HEPES, pH 7.4, 100 mM KCl, and 1 mM CaCl2 
for 2 hours at room temperature. Unbound fluorophores were removed by dialysis. 
Measurement of absorbance at 340 nm (molar extinction coefficient of 3400 M-1cm-1 [85]) 
gave an incorporation of ~1.1 dye units per CaM molecule. Fluorescence measurements 
were performed on a Jobin Yvon Fluoromax-3 spectrofluorimeter at 25°C in 10 mM 
HEPES, pH 7.4, 100 mM KCl, and 1 mM EGTA or CaCl2. Bandwidths were set to 5 nm, 
dansyl was excited at 340 nm, and emission was monitored from 400 to 600 nm. Protein 
and lipid concentrations were 0.2 M and 100 M, respectively. A matching buffer scan 
(blank) was subtracted from each spectrum, and the maximum intensities were read. 
Steady state fluorescence anisotropy measurements were conducted similarly, only 
bandwidths were set to 10 nm and emission was monitored at 510 nm. The fluorescence 
intensities at vertically and horizontally aligned polarizers and analyzers were recorded. 
The blank IVV, IVH, IHH, and IHV values were subtracted from the CaM containing values, 
and anisotropy was calculated from the following equation: 
 
Anisotropy = (IVV – G IVH) / (IVV + 2G IVH), where G = IHV/IHH 
 
3.5. ANS fluorescence 
The presence of micelles was monitored using the fluorescent hydrophobic probe 8-
anilinonaphtalene-1-sulfonic acid (ANS, Fluka, 10417) [86] on a Jobin Yvon Fluoromax-3 
spectrofluorimeter at 25°C. ANS was excited at 388 nm, emission was monitored from 
400 to 600 nm, the excitation slit was adjusted to 2 nm and the emission slit to 5 nm, and 
the maximum intensities were read. The fluorophore concentration was 5 μM in buffer 
consisting of 10 mM HEPES, pH 7.4, 100 mM KCl, and either 1 mM CaCl2 or 1 mM 
EGTA. For determination of the CMC, two straight lines reflecting the aqueous and the 
micellar environments were traced, and the CMC was defined as the concentration 
referring to their point of intersection. For monitoring micelle integrity under conditions 
similar to ITC measurements, 200 μM SPC was titrated with CaM in a concentration 
range of 0.1-20 μM in case of apoCaM and 0.1-40 μM in case of Ca2+CaM. 
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3.6. Calcineurin activity assay 
Calcineurin (PPase-2B) was purchased from Promega (V6361), and the assay was carried 
out based on the protocol of the company. Dephosphorylation of the substrate p-
nitrophenyl phosphate (PNPP, Sigma, 1040) was followed by monitoring the increase in 
absorbance at 405 nm on a Wallac Victor microplate reader. Lipids (100 M in screening 
experiments and 50 M SPC in the CaM dose response experiment) were solubilized in 50 
mM Tris-HCl, pH 7.4, 0.5 mg/ml BSA, 20 mM PNPP, and 1 mM NiCl2. This reaction 
mixture was divided into 4 separate wells on a 96 well plate and either calcineurin (0.001 
unit/μl) or CaM (10 μg/ml), neither or both were added. The plate was incubated at 30°C, 
and the absorbance was read at 405 nm every 2 minutes for 20 minutes. Blank values 
(without added calcineurin) were subtracted before calculating the CaM-dependent and 
independent activities from fitting a linear function to the data. 
 
3.7. X-ray crystallography 
CaM and SPC were co-crystallized using the sitting drop method at room temperature. 2μl 
protein solution at 1 mM concentration was mixed with an equal volume of precipitant 
solution and 10 mM SPC solution in methanol as well as 1.5 μl 0.5% LM agarose gel. The 
precipitant solution was 50 mM sodium cacodylate adjusted to pH 5.5 and containing 10 
mM CaCl2, 10 mM MgCl2, and 28% (w/v) polyethylene glycol 8000. Microseeding was 
carried out 24 h after setting up crystallization. The cryo solution contained 10% glycerol. 
 Data were collected at the ID 23-1 beamline of the European Synchrotron radiation 
Facility. Wavelength of the beam was 0.97620 Å and temperature was set to 100 K. Data 
were processed using Mosflm [87] and scaled using the SCALA program [88]. The 
crystals are isostructural with structures of CaM complexed with various small molecules 
(TFP, arylalkylamine). 
 The structure was solved by molecular replacement using the program MOLREP 
[89] of the Collaborative Computational Project 4 [90]. The N- and C-terminal CaM 
domains of PDB entry 1LIN were used as search models. Refinement was carried out with 
the REFMAC5 program, using TLS refinement and restrained maximum likelihood 
refinement [91]. One TLS domain was defined for both CaM domains and one for the SPC 
molecules. Hydrogen atoms were generated in the riding positions. Model building was 
carried out using the Coot program [92]. 
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 The final model contains CaM residues 3–78 and 80–146, with 12 disordered side 
chains and 3 side chains in alternate positions, as well as 4 calcium ions, 4 SPC molecule 
fragments, and 79 water molecules. The stereochemistry of the structure was assessed with 
PROCHECK [93], 94.4% and 5.6% of the CaM residues are in the most favored and 
additional allowed regions of the Ramachandran plot, respectively. Data collection and 
refinement statistics are shown in Table 3. The atomic coordinates and structure factors 
were deposited in the PDB with accession code 3IF7. 
 
Table 3 Data collection and refinement statistics for the Ca2+CaM / SPC complex 
 
 Ca2+CaM / SPC 
Data collection  
Space group P 3221 
Cell dimensions    
    a, b, c (Å) 39.67, 39.67, 170.34 
    , ,   (°)  90, 90, 120 
Resolution (Å) 29.393-1.60 (1.60-1.69) * 
Rmerge
** 0.105 (0.446) 
I / I 12.3 (4.1) 
Completeness (%) 100.0 (100.0) 
Redundancy 8.6 (7.9) 
  
Refinement  
Resolution (Å) 29.09-1.60 (1.64-1.60) 
No. reflections 20426 (1554) 
Rwork / Rfree 0.195/0.238 (0.200/0.252) 
No. atoms  
    Protein 1096 
    Ligand/ion 80 SPC / 4 Ca2+ 
    Water 79 
B-factors (Å2)  
    Protein 26.664 
    Ligand/ion 48.393 / 18.778 
    Water 34.547 
R.m.s. deviations  
    Bond lengths (Å) 0.025 
    Bond angles (°) 2.085 
 
*Values in parentheses are for highest-resolution shell. **A high resolution and a low resolution 
data set were collected from the same crystal and were merged. 
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3.8. Isothermal titration calorimetry 
Thermodynamics of the interaction of Ca2+CaM and apoCaM with SPC was examined 
using a VP-ITC instrument (MicroCal, Piscataway, NJ, USA). 5-10 μL aliquots of the 
protein at a concentration of 300 or 75 μM in a buffer containing 10 mM HEPES, pH 7.4, 
100 mM KCl and either 5 mM CaCl2 or 1 mM EGTA, was injected into the ITC cell 
containing 200 μM SPC in the same buffer at 25°C. A time interval of ten minutes was 
applied between injections. The analysis of titration curves and the energetics calculations 
were done using the Origin software provided by MicroCal. 
 
3.9. Dynamic light scattering 
Size distributions of SPC-CaM solutions were assessed by an ALV goniometer with a 
Melles Griot diode-pumped solid-state laser at 457.5 nm wavelength (type: 58 BLD 301). 
The intensity of the scattered light was measured at 90° at room temperature. The 
autocorrelation function was calculated using an IBM PC-based data acquisition system 
developed in the Institute of Biophysics and Radiation Biology, Semmelweis University. 
The most probable particle distribution was estimated using the maximum entropy method 
that produces normalized distribution [94]. The hydrodynamic radii of the particles were 
calculated based on the Einstein-Stokes equation. Size distributions calculated in this 
manner bear a standard error of less than 5%. Micelle size distribution is essentially 
independent of total SPC concentration [95], we therefore optimized SPC concentrations 
for the best signal-to-noise ratios. 
 
3.10. Stopped-flow 
All measurements were carried out in a buffer comprising 10 mM HEPES, pH 7.4, 100 
mM KCl and 1 mM CaCl2 at 25 °C. Fluorescence time courses were recorded using an 
SX-20 (Applied Photophysics, UK) stopped-flow apparatus having 2 ms dead-time. 
Dansyl fluorescence was excited at 340 nm and emission was selected with a 455 nm 
long-pass filter. Time courses were analyzed using the curve fitting software provided 
with the stopped-flow apparatus or by Origin 7 (OriginLab Corp., Northampton, MA). At 
least 5 individual curves were collected and averaged for each data point. Each experiment 
was repeated 2-5 times. Error bars represent the sample standard deviation of the average 
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of data points obtained from different experiments. In most amplitude vs. concentration 
graphs no error bars are present due to the fact that signal amplitudes of different curves 
collected at different detector gains are not in the same range. In these cases, amplitudes of 
the actually shown set of curves are presented. Amplitude titration curves are fitted with 
the following quadratic equation (derived in the Supplement of [96]) to extract 
dissociation constants: 
 
( ) ( )
2
* 4* *  / 2*y s A c x K c x K c x c= + + + + +
 
 
s = y at x = 0, A = amplitude, c = concentration of the constant component, K = 
dissociation constant. Errors reported on the fitted parameters comprise not only the fitting 
error, but the standard deviation of the individual data points as well. Kinetic simulation 
was performed using the Gepasi software [97] and the kinetic parameters given in Table 6. 
 
3.11. Equilibrium fluorescence peptide-binding assays 
Peptides representing CaM-binding domains were from several sources. Melittin was 
purchased from Sigma (M 2272). The CaM-binding domain of the skeletal muscle Ca2+ 
release channel (RyR1) [98] and two putative CaM-binding domains from the type 1 IP3 
receptor (IP3R1) [99, 100] were synthesized by Bio-Science Trading Ltd. The CaM-
binding domain of the plasma membrane Ca2+ ATPase (PMCA) [101] was a kind gift of 
Dr. Ágnes Enyedi (National Blood Center, Department of Molecular Cell Biology). For 
the exact sequence of peptides used in the study refer to Table 4. 
 
Table 4 Sequence of peptides used in the study. 
 
CaM-binding peptide Sequence Ref. 
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ [102] 




IP3R1 peptide2 (106-128) ENRKLLGTVIQYGNVIQLLHLKS [99] 
PMCA peptide (2-21) LRRGQILWFRGLNRIQTQI [101] 
 
Fluorescence of dansyl-labeled CaM and of the Trp residue of the RyR peptide 
was monitored on a Jobin Yvon Fluoromax-3 spectrofluorimeter at 25 °C in 10 mM 
HEPES, pH 7.4, 100 mM KCl and 1 mM CaCl2. Bandwidths were set to 5 nm, dansyl was 
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excited at 340 nm, and emission was monitored from 400 to 600 nm. Dansyl-CaM 
titration with melittin was carried out at 0.2 M dansyl-CaM and the resulting curve was 
fitted with the above quadratic equation. When screening with lipids SPC, S1P, LPC, LPA 
and LT-SPC, dansyl-CaM, RyR peptide, and lipid concentrations were 0.2, 0.5 and 100 
M, respectively. When measuring dose-response for SPC, dansyl-CaM and RyR peptide 
concentrations were 0.2 and 0.5 M, respectively, and SPC concentration was varied 
between 10 and 100 M. In the complimentary set of experiments, the Trp residue of the 
RyR peptide was excited at 295 nm, and spectra were recorded from 310 to 400 nm. RyR 
peptide and CaM (unlabeled) concentrations were both 1 M. In screening experiments, 
lipid concentrations were 100 M, while measuring the dose-response, SPC concentration 
was varied between 10 and 100 M. Experiments with dansyl-labeled apoCaM were 
carried out similarly to measurements with Ca2+-saturated CaM, only in buffer containing 
1 mM EGTA instead of 1 mM CaCl2. Measurements with peptides derived from the IP3R1 
and the PMCA were conducted as in the case of the RyR peptide. Mixed micelles were 
prepared by mixing the methanolic stock solutions of the two lipids, and then adding them 
to the appropriate assay buffer. Each spectrum was corrected for corresponding lipid, 
protein, peptide and buffer effects by subtracting a matching buffer scan. 
 
3.12. Single-channel recordings 
Heavy SR vesicles were isolated from rabbit hind limb and back muscle as previously 
described [103]. In the -CaM experiments, endogenous CaM was removed by incubating 
SR vesicles for 30 min at 24 °C with 1 μM myosin light chain kinase-derived CaM 
binding peptide in the presence of 100 μM Ca2+ followed by centrifugation through a layer 
of 15% sucrose to remove complexed CaM and the peptide [59]. For purification, SR 
vesicles were solubilized in CHAPS, purified by sucrose density gradient centrifugation, 
and reconstituted into phosphatidylcholine liposomes [104]. 
Single channel measurements were carried out as previously described [103] in 
planar lipid bilayers containing phosphatidylethanolamine, phosphatidylserine, and 
phosphatidylcholine in the ratio of 5:3:2 (25 mg of total phospholipid/ml of n-decane). 
The side of the bilayer to which the proteoliposomes containing the purified RyR1s were 
added was defined as the cis (cytoplasmic) side. The trans (SR lumenal) side of the bilayer 
was defined as ground. Measurements were made with symmetrical 0.25 M KCl, 20 mM 
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K-HEPES, pH 7.4, with 22 μM free Ca2+ in the cis chamber. The cis solution was varied 
according to experimental conditions. For +CaM samples, proteoliposomes were 
preincubated with 1 M CaM at room temperature for 30 min, and measurements were 
done in the presence of 100 nM CaM in the cis chamber. Data were acquired using test 
potentials of ±35 mV and were sampled at 10 kHz and filtered at 2 kHz. Channel open 
probabilities (Po) were determined from at least 2 min of recordings for each condition. 
 
3.13. [3H]ryanodine binding assays 
SR vesicles were incubated with 2.5 nM [3H]ryanodine for 20 h at room temperature in 
0.3 M sucrose, 0.15 M KCl, 20 mM K-Pipes, pH 7.0, 50x diluted protease inhibitor 
cocktail (Sigma), 0.1 mg/ml BSA, either 5 mM reduced (GSH) or oxidized (GSSG) 
glutathione and 50 μM free Ca2+ (150 μM CaCl2, 100 μM EGTA). Nonspecific binding 
was determined using heat-inactivated SR vesicles. Aliquots of the samples were diluted 
with 10 volumes of ice-cold water and placed on Whatman GF/B filters soaked with 2% 
polyethyleneimine. Filters were washed with three 5-ml volumes of ice-cold 0.1 M KCl, 1 
mM K-Pipes, pH 7.0. Radioactivity remaining with the filters was determined by liquid 
scintillation counting to obtain bound [3H]ryanodine. 
 
3.14. [35S]CaM binding assays 
CaM was metabolically labeled with 35S and purified according to Balshaw et al. [59]. SR 
vesicles were incubated at room temperature for 2 h with 84 nM [35S]CaM in 0.3 M 
sucrose, 0.15 M KCl, 20 mM K-Pipes, pH 7.0, 50x diluted protease inhibitor cocktail 
(Sigma), 0.1 mg/ml BSA, 5 mM GSH and 100 μM free Ca2+ (200 μM CaCl2, 100 μM 
EGTA). Equilibrium [35S]CaM binding was assayed by centrifugation in a Beckman 
Airfuge for 30 min at 90,000 g. Nonspecific binding was determined by measuring 
[35S]CaM binding to heat-inactivated SR vesicles. Bound [35S]CaM was determined by 
scintillation counting after solubilization of pellets in Tris-HCl buffer, pH 8.5, containing 
2% SDS.  
 
 30 
3.15. Ca2+-release measurements on bovine brain microsomes 
Cerebral microsomes were isolated from bovine brain by differential centrifugation based 
on the procedure of Volpe et al. [105]. Measurements of Ca2+ release were performed 
fluorimetrically using Fluo-3 (Molecular Probes, F3715) as a Ca2+ sensor on a Jobin Yvon 
Fluoromax-3 spectrofluorimeter. Microsomes at a concentration of 0.5 mg/ml were 
preloaded with Ca2+ present in 10 mM HEPES, pH 7.2, 100 mM KCl, 5 mM KH2PO4, 1 
mM MgATP, 5 mM phosphocreatine (Sigma, P7936), 20 μg/ml creatine phosphokinase 
(Sigma, C3755) and 2 μM Fluo-3 at 37 °C for 20 min. The excitation slit was adjusted to 1 
nm, the emission slit to 5 nm, Fluo-3 was excited at 506 nm, and emission was monitored 
at 526 nm at 37 °C. Ca2+ efflux was initiated by the addition of either 0.1-100 μM 
ryanodine (Calbiochem, 559276), 5 mM caffeine (Sigma, C0750), 100 μM SPC, LPC, 
LPA or 2 μM Ca2+ ionophore A23187 (Sigma, C7522). Each compound was tested for 
possible artificial signals arising from their effect on Fluo-3 fluorescence by adding them 
to an assay mixture that did not contain microsomes. 
 
3.16. Membrane permeability assay using radioactive Ca2+ 
Proteinless liposomes were prepared from brain total lipid extract purchased from Avanti 
Polar Lipids (131101). Lipids were added from a 30 mM chloroform stock solution, dried 
in glass vials, and resuspended to a final concentration of 1 mM in 10 mM HEPES, pH 
7.4, 100 mM KCl, 1 mM CaCl2 and 5 μCi/ml (approximately 6 μM) 
45Ca2+ (American 
Radiolabeled Chemicals, ARX 0102) by sonication. Liposomes were washed twice with 2 
volumes of buffer free of CaCl2 and 
45Ca2+ by centrifugation at 16,000 g for 10 min. 
Liposomes were resuspended, and either 2 μM A23187 Ca2+ ionophore (Sigma, C7522), 
0.2% saponin, 100 SPC, LPC or LPA were added to trigger Ca2+ release. After 10 min, 
liposomes were centrifuged again, and radioactivity in both the pellets and the 
supernatants were measured by scintillation counting. 
 
3.17. Membrane permeability assay using [14C]glucose 
Skeletal SR vesicles were incubated for 4 h at 0 °C in a large volume (1 mg of protein/ml) 
of incubation medium (0.3 M sucrose, 150 mM KCl, 20 mM K-Pipes, pH 7.0, 50x diluted 
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protease inhibitor cocktail (Sigma), 0.1 mg/ml BSA, 10 mM glucose, 2 mM MgCl2), 
sedimented by centrifugation for 30 min at 35,000 rpm in a Beckman 42.1 rotor, and 
resuspended in a small volume (20 mg of protein/ml) of incubation medium. Vesicles 
were incubated overnight at 4 °C in the presence of 0.1 mCi/ml [14C]glucose. The vesicles 
were then diluted 100-fold into an unlabeled release medium supplemented with the 
appropriate lysophospholipid. Efflux of [14C]glucose was terminated by placing aliquots 
(0.2 ml) on 0.45 μm HAWP Millipore filters followed by rapid rinsing with unlabeled 




4.1. Identification of SPC as a CaM inhibitor 
4.1.1. Fluorescence binding assays indicate a selective interaction between SPC and 
both apo and Ca2+CaM 
As the simplest binding assay to examine whether S1P or SPC interacts with CaM, 
changes caused by the addition of these sphingolipids in the intrinsic Tyr fluorescence of 
the protein were analyzed (Figure 12). 
 
 
Figure 12 Effect of SPC on the intrinsic Tyr fluorescence of CaM. (A) Effect of 
lysophospholipids on apo (white bars) and Ca2+-bound (grey bars) CaM. Protein and lipid 
concentrations were 1 μM and 100 μM, respectively. Results are means ± S.E.M. for at least three 
independent experiments. SPC and LT-SPC treated apoCaM values show significant differences 
(*P<0.01) with regard to the apoCaM control, based on Student’s t test. (B) The average spectra 
for SPC. 1 μM apoCaM ( ), 1 μM Ca2+CaM ( ), 1 μM apoCaM with 100 μM SPC ( ), and 1 
μM Ca2+CaM with 100 μM SPC ( ). (C) Titration of apoCaM with SPC. Protein concentration 
was 1 M and SPC concentration was varied from 5 to 500 M. See inset for the individual 
spectra. Data points represent three independent determinations (Mean ± S.E.M.). Fitting a 
sigmoid function to the data resulted in an apparent KD of 46.9 ± 0.8 μM and a Hill-coefficient of 
3.3 ± 0.2. 
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CaM has two Tyr residues at positions 99 and 138 in the two C-terminal EF-hand 
motifs. Ca2+ binding caused an approximately 2.5-fold increase in fluorescence intensity, 
consistent with previous data [106, 107]. Effects of S1P and SPC, and of the related 
glycerolipid mediators LPA and LPC, were inspected at a concentration of 100 M on 
both apo and Ca2+-saturated CaM. Among these lipids, SPC elicited selective effects, 
causing significant changes in the intrinsic Tyr fluorescence of the apoprotein (Figure 
12A). To address the stereoselectivity of SPC’s action, I also explored the impact of the 
synthetic L-threo stereoisomer, and found that L-threo-SPC modified the intrinsic Tyr 
fluorescence of CaM in the same manner as D-erythro-SPC. It is important to note that the 
naturally occurring stereoisomer is D-erythro-SPC, which I have abbreviated to SPC 
throughout this report. As can be seen from Figure 12B, SPC raised the fluorescence 
intensity of apoCaM approximately 3 fold, resulting in a similar spectrum to that of the 
Ca2+-saturated protein. The binding of SPC could be described by a saturation curve 
resulting in an apparent KD of 46.9 ± 0.8 μM and a Hill-coefficient of 3.3 ± 0.2 (Figure 
12C). 
A change in the fluorescence of dansyl-labeled CaM is another good indicator of 
ligand binding to the protein (Figure 13). Besides recording the fluorescence spectra, the 
steady state anisotropy of the fluorophore, which is sensitive to the radius of giration of 
the molecule carrying the label, was also measured. The same set of lipids were tested, and 
results were consistent with that of Tyr fluorescence. SPC and LT-SPC brought forth 
significant changes in the intensity and anisotropy of both the Ca2+-free and Ca2+-bound 
protein (Figure 13A). The precise anisotropy values could not be determined in case of 
S1P (see high errors), because this sphingolipid greatly elevated the baseline, which I 
could not correct appropriately. Regarding the spectra (Figure 13B), Ca2+ binding caused 
an approximately 1.5 fold elevation in the fluorescence intensity, which was accompanied 
by an approximately 20 nm blue shift, in good agreement with former data [108, 109]. As 
in the case of Tyr fluorescence, SPC enhanced the intensity of apo and, to a smaller extent, 
Ca2+CaM, resulting in a similar spectrum, regardless of the presence or absence of Ca2+. 
The SPC-bound spectra were again closer to that of the Ca2+-saturated protein, but differed 
from it in the intensity and in the wavelength of the maximum intensity as well. Binding 
of SPC to apoCaM followed saturation kinetics resulting in an apparent KD of 21.7 ± 1.3 




Figure 13 Effect of SPC on the fluorescence of dansyl-labeled CaM. (A) Effect of 
lysophospholipids on the steady state anisotropy of apo (white bars) and Ca2+-saturated (grey bars) 
dansyl-labeled CaM. Protein and lipid concentrations were 0.2 μM and 100 μM, respectively. 
Results are means ± S.E.M. for at least three independent experiments. The addition of SPC and 
LT-SPC caused significant differences (*P<0.01) in the anisotropy of both the apo and the Ca2+-
bound protein, with regard to the corresponding controls. (B) The average spectra for SPC. 0.2 μM 
apoCaM ( ), 0.2 μM Ca2+CaM ( ), 0.2 μM apoCaM with 100 μM SPC ( ), and 0.2 μM 
Ca2+CaM with 100 μM SPC ( ). (C) Titration of apoCaM with SPC. Protein concentration was 
0.2 M and SPC concentration was varied from 2 to 200 M. See inset for the individual spectra. 
Data points represent three independent determinations (Mean ± S.E.M.). Fitting a sigmoid 
function to the data resulted in an apparent KD of 21.7 ± 1.3 μM and a Hill-coefficient of 1.8 ± 0.2. 
 
We demonstrated that SPC binds selectively to CaM using surface plasmon 
resonance as well. Furthermore, the sphingolipid does not exert detergent-like effects, it 
binds as a real ligand, as I showed using circular dichroism spectroscopy. These results are 
not presented here, for details refer to [110]. Since my thesis is based on the results of four 
publications, I felt that the amount of data presented in them is too extensive to be part of 
one report without losing coherency. Therefore, I omitted those experiments, which I felt 




4.1.2. SPC micelles are required for efficient binding to CaM 
Since lysophospholipids form micelles in aqueous solutions, the question arises as to 
whether we are seeing a monomeric lipid – protein or a micelle – protein interaction. To 
provide an answer, I measured the critical micelle concentration (CMC) of SPC under our 
experimental conditions. The fluorescent hydrophobic probe ANS exerts increased 
fluorescence in a hydrophobic environment, and as such, is well suited to detect the 
formation of micelles in a solution [86]. Using this method, the CMC of SPC was 
determined to be 33 ± 2 M (Figure 14), and did not depend on the presence of Ca2+. The 
fact that this value is in the same range as the apparent KD values obtained from titrating 
apoCaM with SPC (46.9 ± 0.8 μM when monitoring intrinsic Tyr fluorescence and 21.7 ± 
1.3 μM when monitoring the fluorescence of the dansyl-labeled protein, Figures 12C and 
13C), and the intensive apparent positive cooperativity of the titration curve suggested to 
us that there is a strong interaction between CaM and SPC micelles, whereas SPC 
monomers do not bind efficiently to the protein. Therefore, the dissociation constants 
estimated from titrating with the lipid only provide information about micelle formation 
and do not characterize the strength of the interaction. For determination of the true 




Figure 14 Determination of the critical micelle concentration of SPC. The CMC of SPC was 
determined using the fluorescent hydrophobic probe ANS. Two straight lines reflecting the 
aqueous and the micellar environment were traced, and the CMC was defined as the concentration 
referring to their point of intersection, yielding a CMC of 33 ± 2 M for SPC. Mean and standard 





To rule out the possibility that the specificity of the observed effects arises from 
the different CMC values of the lipids tested, i.e. only SPC forms micelles at the 
concentration at which our experiments were carried out, the CMC of S1P, LPA, LPC, and 
LT-SPC was determined as well (data not shown). I found that the CMC values of each lie 
in the 20-50 M concentration range, thus, each tested lipid forms micelles at a 
concentration of 100 M, at which the screening experiments were conducted. 
 
4.1.3. SPC inhibits CaM function in in vitro enzyme activity assays 
To assess the functional effects of the CaM-SPC interaction, calcineurin, also known as 
Ca2+CaM-dependent protein phosphatase 2B, was chosen as a target enzyme. Calcineurin 
is a heterodimer of a 61 kDa catalytic and CaM-binding subunit, calcineurin A and a 19 
kDa Ca2+-binding regulatory subunit, calcineurin B, which is an EF-hand protein very 
similar to CaM (for a review on calcineurin see [74]). The enzyme reaction can be easily 
followed by monitoring the increase in absorbance at 405 nm, caused by the 
dephosphorylation of the substrate p-nitrophenyl phosphate (PNPP). 
As can be seen in Figure 15A, CaM increased the activity of calcineurin 
approximately 2.5-fold. This activating ability was substantially inhibited in case of SPC 
and LT-SPC, while it was not significantly affected in case of S1P, LPA, and LPC. For 
clarity, fold activation by CaM is shown, because the lysophospholipids slightly 
influenced (S1P increased, whereas SPC, LPC, and LT-SPC decreased) the basal activity 
of calcineurin. 
The concentration dependent inhibition of both the CaM-dependent and 
independent calcineurin activity by SPC is shown in Figure 15B. The IC50 was estimated 
to be 27.4 ± 2.6 μM with a cooperativity coefficient of 2.3 ± 0.4 in case of the CaM-
dependent, and 29.8 ± 3.5 μM with a cooperativity coefficient of 1.7 ± 0.2 in case of the 
basal activity. Since interaction between the two subunits, calcineurin A and CaM-like 
calcineurin B, is essential for activity [74], I hypothesize that the decrease in basal activity 
is a consequence of the fact that SPC disrupts the complex of these two subunits similarly 
to CaM-target interactions (refer to chapter 4.3). To prove that the inhibition of the CaM-
dependent calcineurin activity is a result of CaM inhibition, calcineurin was titrated with 
CaM both in the presence and absence of 50 M SPC (Figure 15C). The fact that excess 
CaM can retain calcineurin activation in the presence of SPC, and that SPC causes a right 
shift of the saturation curve, is indicative of a competitive mechanism. The thousand-fold 
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difference of the EC50 values (2.5 ± 0.4 nM for CaM alone versus 2.9 ± 0.2 M in the 
presence of 50 M SPC) also reveals strong CaM inhibition by SPC. 
 
 
Figure 15 Effect of SPC on the calcineurin activating ability of CaM. Calcineurin activity was 
measured by monitoring the increase in absorbance at 405 nm due to the dephosphorylation of the 
substrate PNPP (20 mM). Calcineurin and CaM concentrations were 0.001 unit/μl, and 10 μg/ml, 
respectively. Data points represent mean ± S.E.M of at least four independent measurements. (A) 
Effect of lysophospholipids (100 M) on the calcineurin activating ability of CaM. Student’s t-test 
revealed significant differences (*P<0.05) for SPC and LT-SPC with regard to control. (B) 
Concentration dependent inhibition of the Ca2+-CaM-dependent ( ) and independent ( ) activity 
of calcineurin by SPC. Fitting a displacement function to the data yielded an IC50 value of 27.4 ± 
2.6 μM with a cooperativity coefficient of 2.3 ± 0.4 in case of the Ca2+-CaM-dependent, and an 
IC50 value of 29.8 ± 3.5 μM with a cooperativity coefficient of 1.7 ± 0.2 in case of the basal 
activity. (C) Dose response curves for the activation of calcineurin by CaM in the presence ( ) 
and absence ( ) of 50 M SPC. Fitting a dose response function to the data yielded an EC50 value 
of 2.5 ± 0.4 nM in case of CaM alone, and an EC50 value of 2.9 ± 0.2 μM in the presence of 50 M 
SPC. 
 
I have also shown that SPC inhibits the phosphodiesterase (PDE1) activating 
ability of CaM, these results are presented in [110]. 
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4.2. Structural characterization of the CaM-SPC interaction 
4.2.1. Crystal structure of the Ca2+CaM/SPC complex 
After the identification of a specific interaction between CaM and SPC, I 
continued research in two main directions. I focused on unraveling the putative functional 
consequences of the interaction and also on giving an in-depth structural and mechanistic 
characterization of the binding process. The latter one was a highly exciting challenge, 
since the fact that SPC binds in a micellar form raised several intriguing questions and 
necessitated special experimental treatment. During the course of our structural studies, 
we have determined the crystal structure of the Ca2+CaM/SPC complex, which I consider 
a huge achievement since lipid-protein interactions are rarely characterized at this level. 
Most of the results I present from here on derive from experimental techniques that require 
special expertise. Therefore, they are not solely my own accomplishments, I have attained 
them in collaboration with experts of a given field. In these cases, I clearly state at the 
beginning of each chapter what my contribution was to the given project. X-ray 
crystallography was carried out in collaboration with Veronika Harmat (ELTE, Laboratory 
of Structural Chemistry and Biology). I have participated in each part of the structure 
determination, including crystallization, data collection at ESRF, Grenoble, model 
refinement and writing the appropriate sections of the manuscript [111]. Of course, 
Veronika is responsible for the substantive work, I mostly learned and participated 
actively in simple tasks. 
The crystal structure of the Ca2+CaM/SPC complex was refined to 1.6 Å resolution 
(Figures 16A and B). The protein is well defined by electron density, except for the central 
linker region and the ends of the protein chain known to be highly flexible and often 
disordered in CaM structures [80, 112-114]. The protein is in a collapsed conformation 
with a binding channel of mainly hydrophobic character formed between its two domains. 
The hydrophobic pockets known to be adaptable to the bound ligand are open. 
Four SPC molecules could be identified in the calculated electron density maps 
(Figure 16C). Their most rigid parts are the long extended alkyl chains bound in nearly 
parallel positions. The binding channel between the two CaM domains is filled by these 
four chains. The alkyl chains of the sphingosyl moiety spread outside the binding channel 
(cca. 17 Å long) and the overhangs are disordered. The phosphocholine moieties could be 
built in electron density maps fully for two SPC molecules and partially for the third one, 




Figure 16 Overall structure of the Ca2+CaM/SPC complex. (A,B) Cartoon representation of 
CaM with the four SPC molecules. Side view (A) shows SPC1 and SPC2 bound in quasy-
symmetry related positions occupying the hydrophobic pockets of CaM. Top view (B) shows the 
four SPC molecules bound in nearly parallel orientations. (C) Stereo view of the electron density 
map contoured at 1.0  level in the SPC binding region. Note that segments of the SPC molecules 
outside the hydrophobic binding region are disordered. The figure was prepared using Pymol 
(DeLano Sci.). 
 
Two of the SPC molecules are bent near their phosphate moieties and fill the 
hydrophobic pockets of CaM, while their positively charged choline groups are pointing 
towards the acidic regions of CaM forming electrostatic interactions. The strongest 
electrostatic interactions of these charged choline groups are established with Glu11 and 
Glu127 (2.9-3 Å) as well as with Glu54 and Glu123 (5.4 Å). The low occupancy of the 
phosphocholine moieties suggests that they are partially disordered in the crystal and 
possibly flexible in solution. This results in a non-directed binding of the phosphocholine 
head group and in a possible mobility of the SPC molecule along its axis within the 
binding channel. 
Most importantly, the overall conformation of CaM is well-defined in our crystal 
structure and resembles its complexes with the small molecules trifluoperazine [82] and 
the arylalkylamine derivative AAA [80] and many of its peptide complexes, e.g. [112, 
113] (Figure 17). Accordingly, residues involved in SPC binding could be also mapped to 
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the small molecule inhibitor and target peptide binding sites (Supplementary Information 
in [111]). In the Ca2+CaM/SPC complex, CaM is in a collapsed overall conformation with 
SPC molecules bound between the two CaM domains. The fact that the lipid occupies the 
same binding pocket as the target peptides of CaM explains competitive inhibition 




Figure 17 The conformation of Ca2+CaM in the Ca2+CaM/SPC structure is collapsed, 
similarly to Ca2+CaM complexes with small molecules and most of its target peptides. The 
structures show overlapping binding sites of the ligands. (A) Structural alignment with the 
Ca2+CaM/4TFP complex (pdb accession code 1LIN). N- and C-terminal CaM domains of the 
Ca2+CaM/SPC complex are colored blue and red, respectively. The compared structure is shown in 
lighter colors. Carbon atoms of the SPC and TFP molecules are shown in orange and green, 
respectively. (B) Structural alignment with the Ca2+CaM/myosin light chain kinase target peptide 
complex (pdb accession code 2K0F). The target peptide is in cyan, with its residues anchoring in 
the hydrophobic pockets of CaM shown as sticks. The figure was prepared using Pymol (DeLano 
Sci.). 
 
4.2.2. Isothermal titration calorimetry provides clues for a two-step binding model 
To thermodynamically characterize the CaM-SPC interaction, isothermal titration 
calorimetry (ITC) measurements were conducted in collaboration with József Kardos 
(ELTE, Department of Biochemistry). We carried out experiments together, he evaluated 
data, while I wrote the corresponding sections of the manuscript [111]. As previously 
mentioned, because binding occurs between the protein and sphingolipid micelles, 
characterization of the interaction requires special treatment. Hence, instead of applying 
the conventional ITC experimental setup of ligand injection, we injected the protein into 
the cell containing 200 μM SPC. By keeping the SPC concentration constant, well above 




Calorimetric traces were obtained both in the presence and absence of Ca2+ (Figure 
18). Parameters obtained from the fitting process are presented in Table 5. H, S, and KD 
values correspond to the binding of one CaM molecule to one apparent binding site. Both 
titrations generated two clearly distinguishable binding processes. The binding of apoCaM 
to SPC was very similar to Ca2+CaM binding to the lipid, only it took place in a narrower 
concentration range, that is, with different stoichiometry (see inset in Figure 18). In case 
of apoCaM, we observed an additional endothermic heat reaction, which gradually 
decreased during the whole experiment and overlapped with the two binding reactions 
(Supplementary Information in [111]). We interpreted this process as micelle 
rearrangement, the effect of which could be removed by subtraction for the whole 
concentration range, yielding an undistorted double binding curve for data evaluation. 
Parameters given for the first process of the Ca2+CaM titration should be taken as 
approximative values (Table 5), because the beginning of the reaction could not be 
resolved. In general, the observed stoichiometry-range for the CaM-SPC interaction is 




Figure 18 Calorimetric traces of titrating 200 μM SPC with Ca2+CaM ( ) or apoCaM ( ). 
Inset depicts the titration with apoCaM on a more appropriate scale. Solid lines show the fit by a 




 The stoichiometry of the two binding processes enabled us to envisage the 
following scenarios. The first, stronger binding, for which the fitting process yielded a 
stoichiometry of 100-200 SPC monomers / protein and a KD of 61 ± 10 nM for Ca
2+CaM, 
and a stoichiometry of 164 ± 5 SPC monomers / protein and a KD of 2.4 ± 0.4 nM for 
apoCaM, may be interpreted as the binding of the protein to available surfaces on 
micelles. The second binding process is weaker, yielding a stoichiometry of 7 ± 0.15 SPC 
monomers / protein and a KD of 2.1 ± 0.2 μM for Ca
2+CaM and a stoichiometry of 40 ± 1 
SPC monomers / protein and a KD of 0.22 ± 0.03 μM for apoCaM, and could result from 
additional protein molecules binding to the micelles. However, this scenario is quite 
unlikely in the case of Ca2+CaM, where the estimated number of SPC monomers per 
protein molecule is 7 at the end of the second ITC phase. This would mean that 
approximately 30 CaM molecules bind to one micelle, which is hardly possible 
considering that the size of the protein and the micelle are comparable (see dynamic light 
scattering results for evidence). More likely, the binding of further CaMs could result in 
the disintegration of micelles by the protein. Ca2+CaM could then isomerize in a collapsed 
conformation wrapped around only a few SPC monomers, as we see in our crystal 
structure. ApoCaM, on the other hand, follows a reaction with the stoichiometry of 
approximately 40 SPC monomers / protein. This stoichiometry would allow the binding of 
several apoCaM molecules to one micelle or alternatively, the disintegration of micelles 
into smaller “parts” stabilized by the protein. 
 
Table 5 Thermodynamic parameters of the CaM – SPC interaction obtained from ITC 
measurements 
 

















Ca2+CaM 100-200b 61±10 -56±1 +46 7±0.15 2.1±0.2 -22.9±0.5 +15 
ApoCaM 164±5 2.4±0.4 -77±1 +65 40±1 0.22±0.03 -24.7±0.6 +15.5 
 
a n1 and n2 are the numbers of SPC molecules bound by one CaM molecule for the given binding 
process. H, S, and KD are values corresponding to the binding of one CaM molecule to one 
apparent binding site. The reliability of the fittings are shown by the error values. Each experiment 
was repeated three times. The deviation between the individual measurements was found to be less 
than 5%.  
b The fitting provided acceptable results in this n1 range, KD1 and H1 values are calculated for n1 = 
200. 
c -T S = R·T·lnKD – H 
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Considering the enthalpy and entropy values (Table 5), we can conclude that both 
reactions are entropically largely unfavorable. A study of Brokx et al. on target peptide 
binding by CaM revealed that binding can be either entropically or enthalpically driven, 
but even in the second case, it is only slightly unfavorable entropically with the highest -
T S value of approximately +5 kcal/mol [117]. In contrast, our titrations yielded -T S 
values of +46 and +65 kcal/mol for the first reaction and +15 and +15.5 kcal/mol for the 
second reaction, in case of Ca2+CaM and apoCaM, respectively. Accordingly, our H 
values are larger compared to the results of Brokx et al. who obtained H values between 
approximately -15 and +15 kcal/mol in contrast to our -56 ± 1 and -77 ± 1 kcal/mol for the 
first reaction and -22.9 ± 0.5 and -24.7 ± 0.6 kcal/mol for the second reaction for Ca2+CaM 
and apoCaM, respectively. On the other hand, G (around -10 kcal/mol) and KD values (in 
the nanomolar range) are similar for interactions of CaM with target peptides and SPC. 
The large differences in the thermodynamic properties between SPC – CaM and single 
ligand – CaM interactions could be explained by the different nature of the two 
interactions. In our experiments, the initial state of SPC is micellar, not monomeric, and 
instead of one ligand, a CaM molecule embraces several SPC molecules upon binding. 
 
4.2.3. Dynamic light scattering affirms that CaM first binds to SPC micelles, which 
are then disintegrated by the protein 
To ascertain the size distribution profile of SPC – CaM mixtures of varying 
stoichiometries, dynamic light scattering (DLS) measurements were carried out in 
collaboration with Károly Módos (SOTE, Institute of Biophysics and Radiation Biology). 
We carried out experiments together, he evaluated data, while I wrote the corresponding 
sections of the manuscript [111]. It is worth noting that the intensity dimension of the DLS 
data (Figure 19) is not informative, since it is greatly influenced by the larger 
contaminating particles in the solution that vary from sample to sample. To compare the 
size distributions of the species present, curves were normalized to their area. The Rh 
values of the peaks correspond to the average hydrodynamic radii of the particles, and are 
therefore the relevant values characterizing the size of a given particle. 
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Figure 19 Dynamic light scattering profiles of different CaM-SPC solutions in case of 
Ca2+CaM (A) and apoCaM (B). Symbols represent 500 μM SPC ( ), 40 μM Ca2+CaM ( ), 40 
μM apoCaM ( ), 200 μM SPC with 8 μM Ca2+CaM ( ), 200 μM SPC with 3 μM apoCaM ( ) 
(plateau of the first ITC phase), 200 μM SPC with 40 μM Ca2+CaM ( ) and 200 μM SPC with 12 
μM apoCaM ( ) (plateau of the second ITC phase). Note that curves are normalized to their area 
and their amplitudes are not informative. Rh values corresponding to the peaks describe the 
average size distribution of the population. 
 
Samples of 40 μM Ca2+CaM and 40 μM apoCaM both gave homogenous size 
distributions of 3.3 nm and 2.6 nm hydrodynamic radii, respectively, in accordance with 
preceding reports [118]. A sample of pure SPC micelles revealed that micelles have an 
average hydrodynamic radius of 3.1 nm. In mixtures of 200 μM SPC with 8 μM Ca2+CaM 
or 3 μM apoCaM (concentrations near the end of the first ITC phase), an increase in 
particle size could be observed compared to SPC-free Ca2+CaM and apoCaM (Figure 19). 
200 μM SPC with 8 μM Ca2+CaM yielded particles with an average hydrodynamic radius 
of 5 nm, while 200 μM SPC with 3 μM apoCaM yielded particles with an average 
hydrodynamic radius of 4.5 nm. At concentrations corresponding to the end of the second 
ITC phase, 200 μM SPC with 40 μM Ca2+CaM or 12 μM apoCaM, the size distribution 
profile decreased substantially in agreement with the hypothesis that the large protein – 
micelle particles are disintegrating. The size distribution became less homogenous, a small 
amount of the large complexes could still be observed. In case of Ca2+CaM the resulting 
particles are significantly smaller than Ca2+CaM alone, which indicates that the protein 
adopts a more compact conformation. Together with the 7 SPC monomers per protein 
stoichiometry estimated from the ITC fitting, this suggests that the ensuing Ca2+CaM / 
SPC complex is in the typical collapsed conformation seen in Ca2+CaM / inhibitor and 
Ca2+CaM / target peptide complexes. 
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4.2.4. ANS fluorescence reveals the disruption of SPC micelles by CaM 
To further verify the proposed model, I monitored micelle integrity during titration with 
CaM. Under conditions identical to that of ITC experiments, we followed the fluorescence 
of the hydrophobic probe, ANS. As the intensity of ANS fluorescence increases greatly 
when incorporated into lipid micelles [86], it is well suited to certify the presence of 
micelles in a solution. The change in ANS fluorescence in the presence of 200 μM SPC 
upon incremental addition of Ca2+CaM or apoCaM is depicted in Figure 20. It is clearly 
demonstrated that increasing protein concentration disrupts micelles, moreover, their 
disruption occurs in the same range of molar ratios (0.02-0.2 for Ca2+CaM and 0.01-0.05 
for apoCaM) as the second phase of the ITC measurements. This observation along with 
the results of the DLS measurements strongly argues for the explanation that the second 
phase witnessed in ITC experiments is a micelle disintegration process. 
 
 
Figure 20 Monitoring micelle integrity with ANS fluorescence. 200 μM SPC was titrated with 
Ca2+CaM ( ) or apoCaM ( ) similarly to ITC measurements only monitoring the fluorescence of 
ANS instead of released heat. Disruption of micelles occurrs in the same range of molar ratios as 
the second phase of ITC measurements. 
 
4.2.5. Kinetic properties of the two-step binding process 
Since several kinetic features of the binding process are presented in the following section 
(Chapter 4.3.), I chose not to show kinetic results obtained under conditions similar to ITC 
measurements in detail. For these, please refer to [111]. Most importantly, determined 
dissociation constants and stoichiometries are close to the ones calculated from ITC 
experiments, suggesting that we observe the same events in both experimental setups. 
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Comparing Figure 21 with Figure 18, it appears even more strikingly that the same 
processes are observed utilizing two utterly different techniques. 
 
 
Figure 21 Fluorescence data from stopped-flow measurements calculated in molar ratios. 50 
μM SPC was mixed with increasing concentrations of apo ( ) or Ca2+ ( ) CaM. 
 
4.3. SPC inhibits CaM function in a competitive manner 
4.3.1. Kinetic characterization of Ca2+CaM binding to target peptides 
As a next step, moving in the direction of functionality, but still continuing the 
mechanistic approach, I wished to understand how exactly SPC inhibits CaM function. For 
addressing this question transient kinetic stopped-flow measurements proved especially 
useful, which are largely the merit of Judit Tóth (Institute of Enzymology). We carried out 
experiments together, while data evaluation, performing kinetic simulations and writing 
the corresponding sections of the manuscript were done by her alone. Although this is the 
part of my thesis, which I contributed to least, I present these results in detail, because 
they are essential to the message I wish to convey, and represent a bridge between our 
structural and functional studies. 
 As the simplest model of CaM-target interactions, we turned to the CaM-melittin 
complex, which is widely used to study the interaction between CaM and the effector 
proteins it regulates [102]. The details of the CaM-melittin binding mechanism, 
nevertheless, have not been revealed before to the degree we needed to study a composite 
system with both putative CaM binding partners  SPC and melittin  present. Previous 
kinetic studies focused on the mutual effect of Ca2+ and target peptide binding to CaM 
[119, 120] and did not aim at characterizing the CaM – peptide interaction at saturating 
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Ca2+ concentration. Therefore, we performed melittin binding experiments both by 
equilibrium and transient kinetic methods using the fluorescence of dansyl-CaM. Dansyl 
labeling was performed in conditions to produce a 1:1 homogeneous labeling to avoid 
artifacts in the transient kinetics experiments. 
 
 
Figure 22 Binding of Ca2+-saturated dansyl-CaM to the model peptide melittin. (A) 
Fluorescence time courses on the reaction of 0.1 μM (final concentration) dansyl-CaM with buffer 
or with 0.15-0.6 μM melittin. Stopped-flow traces are shown in grey, black lines through the data 
represent the best double exponential fits to the curves. The x-axis is shown from t = 0.002 s (the 
dead-time of the stopped-flow apparatus), exponential fits converge to the fluorescence intensity 
level of the „buffer“ curve. (B) Melittin concentration dependence of the observed binding rate 
constants from exponential fits to the stopped-flow traces (fast phase ( ) and slow phase ( )) or 
from kinetic simulation of the same time-courses (fast phase ( ) and slow phase ( )). A linear fit 
to the pseudo-first order part of the curve yielded k+1, M = 1004 ± 366 μM
-1s-1. The rate constants of 
the slow phase (inset, ) did not exhibit concentration dependence and had a first-order k2obs, M = 
49 ± 13 s-1. (C) Amplitude titration extracted from the exponential fits to the stopped-flow traces. 
The quadratic fit (smooth line through the data) to the concentration-dependent fast phase ( ) 
comprising 88% of the total amplitude at the highest measured concentration yielded an apparent 
Kd of 0.3 ± 0.15 μM. The amplitude of the slow phase ( ) exhibited a tendency to decrease with 
concentration. Fitting the total amplitude data ( ) yielded a Kd of 0.067 ± 0.044 μM. (D) 
Equilibrium fluorescence titration of 0.2 μM dansyl-CaM with melittin. The Kd from the quadratic 
fit is 0.054 ± 0.016 μM. 
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Time courses of fluorescence change after mixing dansyl-CaM with melittin are 
biphasic (Figure 22A) indicating at least two biochemical transitions both characterized by 
the expected fluorescence increase [108, 109] upon binding. Time courses were analyzed 
by double exponential fitting. The concentration dependence of the observed rate 
constants of the two phases (Figure 22B) suggests that the fast phase is a second-order 
reaction followed by a slow first-order reaction reflecting some conformational 
reorganization of the CaM-melittin complex (k2obs, M = 49 ± 13 s
-1, Table 6). The 
association rate constant of the second-order reaction was determined from the linear 
phase of the kobs vs. concentration curve, in which range the pseudo first-order 
approximation applies (k+1, M = 1004 ± 366 μM
-1s-1, Table 6). The dissociation rate 
constant could not be reliably extracted from the linear fit because of the large uncertainty 
of the y-intercept. We could extract the dissociation constant of the first process of the 
binding from the concentration dependence of the fast phase amplitude (Figure 22C, Kd1, M 
= 0.3 ± 0.15 μM, Table 6). The total amplitude describing the entire binding process is 
analogous to equilibrium binding data and yielded Kd1-2, M = 0.067 ± 0.044 μM. 
Consistently, equilibrium fluorescence titration of dansyl-CaM with melittin in a 
fluorimeter yielded Kd eq, M = 0.054 ± 0.016 μM (Figure 22D, Table 6) close to the 
previous Kd1-2, M value within error. Taking Equations 1 and 2 (derived in the Supplement 
of [96]) and Kd1-2, M into consideration, we calculated all remaining parameters of the two-
step binding process summarized in Scheme 1. 
 




                    Eq. 1
                           Eq. 2
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Using the kinetic parameters in Scheme 1, we ran numerical simulations for the 
time courses shown in Figure 22A to test the validity of our model. To model the 
experimentally observed time courses, we assumed that the two high fluorescence states 
have similar intensities and thus the observed fluorescence reflects the sum of the 
concentrations of the two populations (* and ** in Scheme 1). The simulated time courses 
were subjected to the same analysis procedures as the experimental data. As a result, kobs 
values showed good agreement with the experimentally obtained ones (Figure 22B) 





4.3.2. Kinetic evidence for a competitive mechanism by which SPC interferes with 
Ca2+CaM-target interactions 
We wished to characterize the kinetics of the interaction between dansyl-CaM and SPC as 
we did for the CaM-peptide interaction. Fluorescence time courses upon mixing dansyl-
CaM with various concentrations of SPC proved to be extremely fast and yielded only 
small fluorescence changes. Even at the lowest SPC concentration the course of 
fluorescence change was lost in the 2 ms dead-time of the stopped-flow apparatus and is 
therefore not shown. We can only put a lower estimate on the association rate constant 
(k+1, S > 40 μM
-1s-1, Table 6). As a result of these SPC-binding experiments we conclude 
that Ca2+CaM binding to SPC is fast and saturated above the CMC which is relevant for 
designing the competition experiments. 
 
Table 6 Measured kinetic and thermodynamic parameters of the interaction of Ca2+CaM 
with melittin or with SPC. 
 
 
Explanation of the indexes: M, parameter obtained for CaM – melittin binding; S, parameter 
obtained for CaM – SPC binding; C, parameter obtained in a chasing experiment; +/- signs and 
numbers indicate specific reaction steps as shown in Scheme 1. 
Experiment Parameter Value Dimension Figure 
k+1, M 1004 ± 366 μM
-1s-1 22B 
k-2, M + k+2, M 49 ±13 s
-1 22B 
Kd1, M 0.3 ± 0.15 μM 22C 
Kd1-2, M 0.067 ± 0.044 μM 22C 
CaM-ME binding 
 
Kd eq, M 0.054 ± 0.016 μM 22D 
CaM-SPC binding k+1, S > 40 μM
-1s-1 - 
SPC micelle formation CMC 33 ± 2 μM 14 
Kd1-2, SC 32 ± 0.7 μM 23B 
Kd1, SC 51 ± 3 μM 23B 
k+1, SC 2.4 ± 0.2 μM
-1s-1 23C 
k1 sat, SC 348 ± 30 s
-1 23C 
k2obs, SC 14 ± 6 s
-1 23C 
SPC chase 
k3obs, SC 0.9 ± 0.3 s
-1 23C 
Kd1-2, MC 1.0 ± 0.3 μM 24B 
k1 sat, MC 59 ± 13 s
-1 24C 
K1app, MC  5.4 ± 3.4 μM 24C 
ME chase 
k2obs, MC 4-8 s
-1 24C 
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We reacted pre-mixed dansyl-CaM  melittin complexes with various 
concentrations of SPC to investigate whether these two ligands compete with each other 
for the same CaM target site. Luckily, formation of the two different dansyl-CaM 
complexes display opposite fluorescence changes and thus transformation of one complex 




Figure 23 Kinetics of the interaction of SPC with the Ca2+-saturated dansyl-CaM – melittin 
complex. (A) Time courses of melittin dissociation from dansyl-CaM after mixing an equilibrated 
sample of 0.4 μM dansyl-CaM and 0.8 μM melittin with 0-500 μM SPC (pre-mix concentrations). 
The first trace was best fitted with single, the second with double and further curves with triple 
exponentials represented by the smooth lines through the data. (B) Concentration dependence of 
the amplitudes (inset, A1 ( ), A2 ( ), A3 ( )) and maximal fluorescence changes derived from 
the exponential fits to the stopped-flow traces shown in panel A. Maximal fluorescence change 
was calculated from the ymax value of the exponential fits. A Hill equation having n = 4 ± 0.4 and a 
half-maximal signal change at [SPC] = 32 ± 0.7 μM, close to the previously determined CMC for 
SPC, provided the best fit to the curve. Similar fit to the amplitude of the fast phase yielded n = 3 ± 
0.5 and A1max/2 = 51 ± 3 μM. At saturation, the three observed kinetic phases A1, A2 and A3 take a 
78%, 4%, 18% share of the total amplitude, respectively. (C) SPC concentration dependence of the 
observed rate constants of the fast (main panel, ) and slow (inset, k2 ( ), k3 ( )) phases. The 
fast phase data showed linear concentration dependence and reached saturation at about 150 μM 
SPC with k1 sat, SC = 348 ± 30 s
-1. The two slower phases did not depend on SPC concentration in 
the measured range and varied in the range of k2obs, SC = 14 ± 6 s
-1 and k3obs, SC = 0.9 ± 0.3 s
-1. 
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The large fluorescence decrease upon mixing indicated that SPC replaced the 
previously bound melittin on dansyl-CaM (Figure 23A). Time courses could be fitted with 
one (1st data point), two (2nd data point) or three exponentials. The slower kinetic phases 
have smaller amplitudes, which may explain why they go unseen when the total amplitude 
is relatively small (first data points). The first, concentration dependent, fast phase 
corresponds to SPC binding to dansyl-CaM and is characterized by a cooperative 
amplitude saturation curve (Figure 23B), which probably reflects micelle formation 
(parameters in Table 6). As previously observed, above the CMC the fluorescence change 
becomes saturated. The kobs of the fast phase saturates at about 350 s
-1 (Figure 23C, k1sat, SC 
in Table 6), close to the value of the rate constant estimated for CaM-melittin dissociation 
(k-1, M = 301 s
-1, Scheme 1). The first-order rate constant observed for the second phase 
(k2obs, SC = 14 ± 6 s
-1) is also almost equal to k-2, M (11 s
-1, Scheme 1) in the melittin 
binding mechanism. These observations imply that SPC binding to CaM is limited by the 
dissociation of melittin. The initially melittin-saturated dansyl-CaM  melittin complex 
(mostly populates the dCaM.ME** state in Scheme 1) must go through the kinetic steps 
characterized by k-2,M and k-1,M before SPC can associate with CaM. The apparent SPC-
CaM association (k+1,SC = 2.4 ± 0.2 μM
-1s-1) is not as fast as in the case of SPC binding to 
pure dansyl-CaM because melittin re-binding occurs and the observed rates are set as a 
function of the concentration ratios and kinetic parameters of the two ligands. A third 
kinetic phase with a slow observed rate constant of k3obs, SC = 0.9 ± 0.3 s
-1 and an 18% 
relative amplitude appears at [SPC] > CMC possibly due to a conformational change in 
the dansyl-CaM  micelle complex. 
We also carried out the reverse chasing experiment in which dansyl-CaM saturated 
with SPC was mixed with various concentrations of melittin (Figure 24). We again 
expected large fluorescence changes, fluorescence increase this time, as SPC exchanges to 
melittin on dansyl-CaM (CaM.SPC  CaM.ME**). Time courses followed double 
exponentials (Figure 24A) and the fluorescence change exhibited hyperbolic saturation 
with an apparent dissociation constant of 1 μM (Figure 24B, K d1-2, MC = 1.0 ± 0.3 μM, 
Table 6). The observed rate constants of both phases were dependent on melittin 
concentration in the measured concentration range (Figure 24C). The fast phase exhibited 
a saturating character and could be fitted with a hyperbole that saturates at k1 sat, MC = 59 ± 
13 s-1. This rate constant likely originates from the one observed for the second process in 
melittin binding which is in the same range within error (k+2, M + k-2, M = 49 ± 13 s
-1). At 
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infinite melittin concentration, the initial binding of melittin (characterized by k+1, M * 
[CaM]) will be fast and saturated, thus, the entire binding process will be limited by the 
second, slower kinetic step. The apparent half maximal saturation of the fast phase (K1app, 
MC = 5.4 ± 3.4 μM) is the result of an interplay between the three reversible processes 
(CaM + ME ⇌ CaM.ME* ⇌ CaM.ME**, CaM + SPC ⇌ CaM.SPC), and it appears to be 
close to the equilibrium constant calculated for the second CaM – melittin binding step.  
 
 
Figure 24 Dissociation of the Ca2+-saturated dansyl-CaM  SPC complex by melittin. (A) 
Time courses of the chasing experiment. Equilibrated 0.4 μM dansyl-CaM and 100 μM SPC was 
mixed with 0-20 μM melittin (pre-mix concentrations). Smooth lines represent double exponential 
fits to the data. (B) Concentration dependence of the amplitudes (fast phase ( ), slow phase ( ) 
and total amplitude ( )) derived from exponential fits to the stopped-flow traces. The best 
quadratic fit to the total amplitude curve yielded an apparent Kd1-2, MC of 1 ± 0.3 μM. (C) 
Concentration dependence of the observed rate constants of the fast ( ) and slow ( ) phases. The 
fast phase was best fitted with a quadratic equation having an y-intercept at 10 ± 4 s-1, a rate 
constant of 59 ± 13 s-1 at saturation and an apparent Kd = 5.4 ± 3.4 μM. The slow phase exhibited a 
weak dependence on melittin concentration and the kobs varied between 4-8 s
-1. (D) Analysis of 
simulated time courses. Kinetic parameters used for the simulation are shown in Table 6. 
Concentration dependence of the amplitudes of exponential fits to the simulated curves (fast phase 
( ), slow phase ( ) and total amplitude ( )). The best quadratic fit to the total amplitude curve 
yielded an apparent Kd of 1.5 ± 0.12 μM. 
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The slow phase (4-8 s-1) represents the smaller portion of the total amplitude. On 
the basis of our parallel binding model, it should originate from the dissociation of the 
CaM – micelle complex (consistently with the relatively small signal change observed 
upon the CaM – SPC interaction) and is expected to reach saturation (kobs sat = k-1, S). Since 
micelle binding to CaM was too fast to be measured, these observed rate constants are the 
only accessible parameters to indicate that k-1, S is relatively slow. 
We formulated a relation between the thermodynamic parameters of CaM binding 
to either SPC or melittin and the apparent Kd-s of the chasing experiments (Equation 3; for 













                      Eq. 3      
 
 Where C represents the chaser, L represents the prebound ligand, and KL and KC 
indicate the dissociation constants for the ligand and the chaser. Substituting the 
previously determined values for KC (~ 60 nM, Figures 22C-D, Kd1-2, M and Kd eq, M in 
Table 6), Kd,app (1 μM, Figure 24B and K d1-2, MC in Table 6) and L (50 μM) into Eq. 3, we 
calculate the experimentally inaccessible parameter, KL to be 3 μM (in SPC monomer 
concentration). This corresponds to 3/n μM in SPC micelle concentration, where n is the 
number of monomers per micelle. From results presented in Chapter 4.2, we estimate the 
molecular ratio to be 100-200 monomers per micelle, which would imply that the Kd for 
the dansyl-CaM  micelle complex is 0.015-0.03 μM. 
We performed kinetic simulations to test if our kinetic model is plausible taking an 
average size of 150 monomers/micelle into account. We used the herein defined kinetic 
parameters and relative fluorescence levels of 2 and 0.8 for the dansyl-CaM  melittin and 
dansyl-CaM  micelle complexes, respectively, compared to free dansyl-CaM. By 
simulating the experiment shown in Figure 24A, we obtained double exponential curves 
similar to the measured ones. The amplitude analysis of the simulated curves (Figure 24D) 
resulted in an apparent Kd of 1.5 ± 0.12 μM, close to the experimentally determined 1 μM. 
Simulated kobs values were also in the range of the measured ones. As a summary of our 
results on the SPC-melittin competition experiments we suggest a model shown in Figure 
35 in the Discussion section. 
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4.4. Putative functional consequences of the CaM-SPC interaction 
4.4.1. SPC dissociates the complex between Ca2+-saturated CaM and the CaM-
binding domain of RyR1 
To investigate the possible functional consequences of CaM inhibition by SPC, I 
examined the impact of SPC on interactions between CaM and CaM-binding domains of 
proteins involved in Ca2+ homeostasis, since the best described function of SPC as a 
putative second messenger is the liberation of Ca2+ from intracellular stores [50, 51]. As 
SPC has been suggested to be involved in activation of ryanodine receptors (RyRs) [40, 
56], I started working with the CaM-binding domain (amino acids 3614-3643) of the 
skeletal muscle Ca2+ release channel (RyR1) [98]. By monitoring the fluorescence of both 
the dansyl-labeled protein and the Trp of the RyR1 peptide, I was able to examine their 
interaction from the aspect of both CaM and the Ca2+ channel. As both fluorescence 
signals undergo large changes upon complexation, they provide a convenient method to 
distinguish whether a third compound dissociates the complex or not. 
The fluorescence intensity of dansyl-labeled Ca2+-saturated CaM increases 
approximately 2-fold accompanied by an approximately 30 nm blue-shift upon binding to 
its target peptide on the RyR. After the addition of saturating amounts of SPC to the 
peptide  CaM complex, the spectrum resembles the SPC-bound form of dansyl-labeled 
CaM, implying that the peptide was replaced by SPC on CaM (Figure 25A). We have 
demonstrated that this complex-dissociating effect of SPC is selective compared to 
structurally and functionally related lysophospholipids S1P, LPC and LPA, whereas L-
threo-SPC is also potent (Figure 25C). SPC’s action can be described with an EC50 value 
of 19.4 ± 1.4 μM and a cooperativity coefficient of 2.6 ± 0.4 (Figure 25E). 
In the complementary experiment, when monitoring the Trp fluorescence of the 
RyR peptide, the acquired results correspond exactly to the ones obtained using dansyl-
CaM fluorescence as a reporter. Binding of Ca2+-saturated CaM brought forth an 
approximately 2.5-fold increase in Trp fluorescence intensity and an approximately 20 nm 
blueshift. The addition of SPC resulted in a spectrum similar to the spectrum of the free 
RyR peptide (Figure 25B). This effect was again specific (Figure 25D), and gave an EC50 
value of 19.3 ± 3.4 μM and a cooperativity coefficient of 2.2 ± 0.8 (Figure 25F), very 




Figure 25 Dissociation of the complex between Ca2+CaM and the CaM-binding domain of 
RyR1 by SPC, revealed by the fluorescence of dansyl-labeled CaM and the Trp of the RyR 
peptide. (A) Spectra of 0.2 μM Ca2+-saturated dansyl-CaM ( ), 0.2 μM Ca2+-saturated dansyl-
CaM with 0.5 μM RyR peptide ( ), 0.2 μM Ca2+-saturated dansyl-CaM in the presence of 100 
μM SPC ( ) and 0.2 μM Ca2+-saturated dansyl-CaM in the presence of 0.5 μM RyR peptide and 
100 μM SPC ( ). (B) Spectra of 1 μM RyR peptide ( ), 1 μM RyR peptide with 1 μM Ca2+CaM 
( ), 1 μM RyR peptide in the presence of 100 μM SPC ( ) and 1 μM RyR peptide in the 
presence of 1 μM Ca2+CaM and 100 μM SPC ( ). Spectra in panels A and B are averaged from 
three independent measurements. (C) Effect of related lysophospholipids on the interaction 
between Ca2+CaM and the CaM-binding domain of RyR1. Bars depict the fluorescence intensity of 
0.2 μM Ca2+-saturated dansyl-CaM in the presence of 0.5 μM RyR peptide and 100 μM lipids. (D) 
The same as in panel C, but measuring the Trp fluorescence of the RyR peptide. Bars depict the 
fluorescence intensity of 1 μM RyR peptide in the presence of 1 μM Ca2+CaM and 100 μM lipids. 
Mean and standard error values in panels C and D were calculated from three independent 
experiments. The addition of SPC and LT-SPC brought forth a significant decrease in intensity 
(p<0.05, see asterisks), based on Student’s t-test. (E) Concentration dependence of the complex 
dissociating ability of SPC. Ca2+-saturated dansyl-CaM and RyR peptide concentrations were 0.2 
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μM and 0.5 μM, respectively. (F) The same as in panel E, but measuring the Trp fluorescence of 
the RyR peptide. RyR peptide and Ca2+CaM concentrations were both 1 μM. Data points in panels 
E and F represent the mean and standard error values of three independent determinations. Fitting 
a sigmoidal dose-response function yielded an EC50 value of 19.4 ± 1.4 μM with a cooperativity 
coefficient of 2.6 ± 0.4 in case of dansyl-CaM, and an EC50 value of 19.3 ± 3.4 μM with a 
cooperativity coefficient of 2.2 ± 0.8 in case of Trp fluorescence of the peptide. 
 
4.4.2. SPC dissociates the complex between apoCaM and the CaM-binding domain of 
RyR1 
Calcium binding to CaM leads to an N-terminal shift in its binding site on the RyR, hence 
this region of the channel possesses the unique feature of containing a distinct binding site 
for both apo and Ca2+-saturated CaM [98]. As mentioned in the Introduction, traditional 
CaM inhibitors only interact with Ca2+-saturated CaM, while SPC binds to both forms of 
the protein. Thus, I investigated the effect of SPC on the apoCaM – RyR peptide 
interaction. Though the complex formation between apoCaM and the RyR peptide yielded 
significantly smaller changes in fluorescence than in the case of Ca2+-saturated CaM, the 
complex dissociating ability of SPC could still be demonstrated. The spectra of dansyl-
labeled apoCaM revealed that if saturating amounts of SPC are present, the protein is 
predominantly bound to the sphingolipid (Figure 26). 
 
 
Figure 26 Dissociation of the complex between apoCaM and the CaM-binding domain of 
RyR1 by SPC. Spectra of 0.2 μM dansyl-labeled apoCaM ( ), 0.2 μM dansyl-labeled apoCaM 
with 0.5 μM RyR peptide ( ), 0.2 μM dansyl-labeled apoCaM in the presence of 100 μM SPC 
( ) and 0.2 μM dansyl-labeled apoCaM in the presence of 0.5 μM RyR peptide and 100 μM SPC 
( ). Spectra are averaged from three independent measurements. 
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4.4.3. SPC dissociates the complex between Ca2+-saturated CaM and the CaM-
binding domain of several proteins involved in Ca2+ homeostasis 
The effect of SPC on the interaction of CaM with further CaM-binding proteins involved 
in Ca2+ homeostasis was also explored. Besides the RyR1 peptide, two peptides 
corresponding to residues 1564-1585 and 106-128 of the type 1 IP3 receptor (IP3R1) and a 
peptide corresponding to residues 2-21 of the human erythrocyte plasma membrane Ca2+-
ATPase (PMCA) was examined. For details on these peptides refer to Table 4. I found that 
SPC disrupted the complex between each of these peptides and Ca2+-saturated CaM, as the 
fluorescence of the dansyl-labeled protein in the presence of both the peptide and SPC 
resembled the SPC-bound form (Figure 27). Other lysophospholipids such as S1P, LPC 
and LPA did not significantly affect the fluorescence of the CaM-target complex. 
 
 
Figure 27 SPC-induced dissociation of complexes between Ca2+CaM and peptides derived 
from proteins involved in Ca2+ homeostasis. Bars depict the fluorescence intensity of 0.2 μM 
Ca2+-saturated dansyl-CaM with peptides from RyR1, IP3R1 and PMCA (see Table 4 for details) at 
a concentration of 0.5 μM, in the absence (white bars) and in the presence (grey bars) of 100 μM 
SPC, S1P, LPC and LPA, respectively. Mean and standard error values were calculated from three 
independent experiments, and the asterisks represent significant decrease (p<0.05), based on 
Student’s t-test. 
 
4.4.4. SPC exerts its effects in mixed micelles, more relevant to in vivo conditions 
To assess whether SPC can displace CaM from its targets under conditions more 
resembling the in vivo situation, experiments with mixed micelles were carried out. In 
these experiments, varying amounts of SPC were incorporated into micelles consisting of 
lipids that did not have any significant effect on the CaM – target peptide system, such as 
S1P, LPC and LPA. Figure 28A clearly demonstrates that SPC dissociates the CaM – 
 58 
peptide complex in the presence of other lipids just as potently as pure SPC. To 
comprehend the effect of “dilution” caused by other lipids, I measured the dose-response 
of complex dissociation in case of SPC/LPC mixed micelles keeping the SPC content at a 
constant 20% (Figure 28B). Comparing these results with the dose-response for pure SPC 
revealed that the fluorescence of dansyl-CaM changes less steeply in the case of mixed 
micelles. A possible explanation for this phenomenon might be that at lower 
concentrations additional lipids aid the effect of SPC’s action by forming micelles at lower 
SPC concentrations. While at higher concentrations, the presence of other lipids seems to 
have a minor negative diluting effect on SPC’s ability to interfere with CaM function. 
These observations point to the potential of SPC to displace CaM under in vivo conditions 
near membrane surfaces enriched in the signaling sphingolipid. 
 
 
Figure 28 Effect of SPC on the Ca2+-saturated CaM – RyR1 peptide complex in mixed 
micelles. (A) Bars depict the fluorescence intensity of 0.2 μM Ca2+-saturated dansyl-CaM with 0.5 
μM RyR1 peptide in the absence (white bars) and in the presence of pure SPC (lightest grey bar) 
or mixed micelles of varying amounts of SPC incorporated into either S1P, LPC or LPA micelles, 
respectively (darker grey bars). Total lipid concentration was held constant at 100 μM, and mixed 
micelles contained either 20 or 50 μM SPC. Error bars depict an average experimental error of 5 
%. (B) Concentration dependence of the complex dissociating ability of 20 % SPC containing LPC 
micelles ( ) compared to pure SPC ( ) taken from Figure 25E. Ca2+-saturated dansyl-CaM and 
RyR peptide concentrations were 0.2 μM and 0.5 μM, respectively. In contrast to panel A, the total 
lipid concentration varied, and the SPC content was held constant at 20 %. Data points represent 
the mean and standard error values of three independent measurements. 
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4.5. SPC regulates RyRs through both CaM-dependent and -independent 
mechanisms 
4.5.1. Monomeric SPC induces long channel closings of purified RyR1 independently 
of CaM 
To explore the effect of SPC on the intact RyR, I visited the laboratory of Dr. Gerhard 
Meissner at the University of North Carolina, Chapel Hill in the framework of an EMBO 
Short-term Fellowship. The following experiments were conducted in his laboratory, RyR 
preparations were provided by Daniel Pasek, single channel recordings were carried out 




Figure 29 Effects of SPC on single channel activities of purified RyR1 in absence and 
presence of CaM. (A) Single channel currents were recorded at +35 mV before (top 3 traces) and 
after the addition of 1 μM SPC cis (bottom 3 traces) in symmetrical 0.25 M KCl in presence of 22 
μM free Ca2+ cis and absence of CaM. The closed states are indicated by c--. (B) As in (A) in 
presence of 100 nM CaM. Proteoliposomes were incubated with 1 μM CaM for 30 min before the 
addition to the cis chamber of the lipid bilayer system, and channels were recorded in presence of 
100 nM CaM in the cis chamber. (C) Dependence of purified RyR1 channel activity on SPC 
concentration in absence and presence of CaM. Relative open channel probability (Po/Po,control) was 
obtained from single channel recordings similar to those shown in panels A and B. Solid lines 
were obtained according to the equation Po = Po,control (1 + [SPC]/Ki)
-1, where Ki is the inhibition 
constant and Po and Po,control are single channel open probabilities in presence and absence of SPC. 
Inhibition constants in the absence (n=6) and presence (n=10) of 1μM CaM were 1.3 ± 0.3 μM and 
0.7 ± 0.2 μM, respectively. 
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The effects of SPC on the skeletal muscle ryanodine receptor (RyR1) both in the 
presence and absence of CaM were studied with the method of single channel recordings 
in planar lipid bilayers. Proteoliposomes containing purified RyR1 were fused with the 
lipid bilayer and the resulting channel activities were recorded. Figure 29A shows a 
representative single channel recording in the absence (upper panel) and after the addition 
of 1 M SPC (lower panel) to the cis chamber with 22 M free Ca2+ in the cis chamber. 
Addition of SPC decreased single channel open probability (Po) from 0.51 to 0.16. The 
lipid induced long channel closings without noticeably altering the duration of open 
events. In Figure 29B, the effects of the lipid on RyR1 were measured in the presence of 
100 nM CaM in the cis chamber. To assure CaM binding to RyR1, proteoliposomes were 
preincubated with 1 M CaM for 30 min. Addition of 1 M SPC reduced Po from 0.15 to 
0.05 by inducing long channel closings, similarly to those observed in the absence of 
CaM. The open probability of the channel was decreased by SPC with an IC50 of 1.3 ± 0.3 
μM and 0.7 ± 0.2 μM in the absence and presence of 1 μM CaM, respectively (Figure 
29C).  
 
Table 7 Effect of SPC on purified RyR1 channel parameters in the absence and presence of 
CaM 
 
Additions to cis bilayer chamber 
22 M Ca2+ 22 M Ca2+ and 1 M CaM Channel parameter 
–1 M SPC +1 M SPC –1 M SPC +1 M SPC 
No. of events 19,874 ± 7337 9767 ± 1884 20,544 ± 4074 10,392 ±2633* 
Po 0.52 ± 0.16 0.24 ± 0.10 0.39 ± 0.12 0.18 ± 0.09* 
Ao1 0.87 ± 0.12 0.81 ± 0.18 0.91 ± 0.08 0.94 ± 0.05 
Ao2 0.13 ± 0.12 0.19 ± 0.18 0.09 ± 0.08 0.06 ± 0.05 
o1 (ms) 0.56 ± 0.53 0.24 ± 0.19 0.26 ± 0.22 0.16 ± 0.12 
o2 (ms) 2.93 ± 2.22 5.09 ± 3.32 1.48 ± 0.85 3.12 ± 2.10 
Ac1 0.98 ± 0.01 0.994 ± 0.003 0.85 ± 0.09 0.96 ±0.03 
Ac2 0.02 ± 0.01 0.006 ± 0.003 0.15 ± 0.09 0.04 ± 0.03 
c1 (ms) 0.05 ± 0.02 1.07 ± 0.68 0.77 ± 0.47 2.81 ± 1.66 
c2 (ms) 3.21 ± 2.09 452 ± 140* 16.53 ± 6.21 619 ± 242* 
 
Channel parameters were obtained from 2 min continuous recordings as described in Experimental 
Procedures. Po refers to open channel probability. Dwell-time data were fitted by the maximum 
likelihood method to the probability density function: f(t) = Ai (1/ i) exp (-t/ i), where Ai and i 
are the relative areas of the distributions and time constants of the ith state, respectively [123]. 
Both the open and closed time histograms could be fitted by the sum of two exponentials. 
*Values significantly different from the –SPC control (P < 0.05; n = 4 and 6 in case of –CaM and 





Analysis of single channel recordings showed that, both in the absence and 
presence of CaM, the open and closed times of Ca2+-activated channels could be fitted by 
the sum of two exponentials (data not shown), in agreement with a previous report [122]. 
SPC significantly increased the lifetimes of the second closed state (an increase from 3.21 
± 2.09 ms to 452 ± 140 ms and from 16.53 ± 6.21 ms to 619 ± 242 ms in the absence and 
presence of 1 μM CaM, respectively, Table 7). 
 
4.5.2. Micellar SPC affects [3H]ryanodine binding in a CaM-dependent and -
independent manner 
According to our previous results, in order to see an effect on the Ca2+ sensor, SPC would 
have to be applied at concentrations near its CMC. We could not study the effects of 
micellar SPC in single channel measurements, because the lipid bilayer broke at SPC 
concentrations above 10 μM. To explore the effect of SPC on RyR activity at 
concentrations expected to disrupt the CaM-RyR interaction, [3H]ryanodine binding 
assays were conducted. This ligand binding assay is a good indicator of channel activity, 
since the plant alkaloid ryanodine has been shown to bind with higher affinity to the open 
than the closed channel state [124]. 
 Measurements with skeletal SR vesicles at 50 μM free Ca2+, under both 
reducing (5 mM GSH) and oxidizing (5 mM GSSG) conditions were carried out. Ca2+ 
concentration was optimized to saturate CaM, but not to inhibit RyR activity directly [59]. 
An oxidizing environment is expected to yield higher ryanodine but lower CaM binding, 
while CaM is expected to be inhibitory under both conditions [59]. In the absence of CaM, 
SPC inhibited [3H]ryanodine binding with an apparent IC50 of 26.1 ± 0.8 μM (Figure 30A) 
and 25.5 ± 4.0 μM (Figure 30C) under reducing and oxidizing conditions, respectively. 
These values are approximately 20-fold higher than the ones obtained in the single 
channel measurements and may have been caused by the different SPC to membrane lipid 
ratios in the two techniques. The effect of SPC was selective compared to structurally 
similar lysophospholipid mediators such as LPC and LPA, but a minor inhibitory effect 
could also be observed in case of S1P (Figures 30B and D). 
 In the presence of CaM, on the other hand, SPC did not significantly alter 
[3H]ryanodine binding. A possible explanation for this finding is that SPC exerts two 
opposing effects on the Ca2+CaM-bound RyR. Displacement of inhibitory Ca2+CaM from 
RyR1 has an activating effect, whereas direct interaction with RyR1 is inhibitory, negating 
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the effects of SPC. [35S]CaM binding studies (see below) and the fact that S1P (which 
does not interact with CaM) further decreased [3H]ryanodine binding in the presence of 
CaM (Figure 30D), favour this explanation. 
 
 
Figure 30 Effect of SPC on [3H]ryanodine binding to skeletal SR vesicles. Free Ca2+ 
concentration was set to 50 μM and either 5 mM GSH (A,B) or 5 mM GSSG (C,D) was added. 
Open circles and light bars depict [3H]ryanodine binding in the absence of CaM, while closed 
circles and dark bars depict [3H]ryanodine binding in the presence of 0.1 μM (A,B) and 1 μM 
(C,D) CaM. In the absence of CaM, the dose-response for SPC yielded an apparent IC50 of 26.1 ± 
0.8 μM and 25.5 ± 4.0 μM and a Hill-slope of -1.7 ± 0.04 and -2.9 ± 0.2 under reducing (A) and 
oxidizing (C) conditions, respectively. Data points depict mean ± S.E. (n=3), a sigmoidal dose-
response curve with variable slope was fitted to the data, and asterisks denote significant 
differences at p<0.05 compared to control, based on Student’s t-tests. 
 
4.5.3. SPC displaces CaM from skeletal muscle SR vesicles 
[35S]CaM binding assays revealed that SPC displaces Ca2+-saturated CaM from skeletal 
SR vesicles enriched in RyR1 with an IC50 of 14.2 ± 0.8 μM (Figure 31A). This value 
compares well with the results of peptide binding assays (IC50 = 19.4 ± 1.4 μM, Figure 
25). S1P and LPA were ineffective, while LPC also decreased [35S]CaM binding to SR 
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vesicles (Figure 31B). This effect is probably an artefact as LPC also decreased 
nonspecific binding, and it was without action in peptide binding experiments (Figure 25). 
 
 
Figure 31 Displacement of [35S]CaM from RyR1 by SPC. (A) SPC dissociates Ca2+-saturated 
[35S]CaM from skeletal SR vesicles rich in RyR1 with an IC50 of 14.2 ± 0.8 μM and a Hill-slope of 
2.3 ± 0.7. Data points depict mean ± S.E. (n=3), a sigmoidal dose-response curve with variable 
slope was fitted to the data. (B) Among the tested lysophospholipids, SPC and LPC significantly 
decrease [35S]CaM binding to skeletal SR vesicles. Data points depict mean ± S.E. (n=3), asterisks 
denote significant differences at p<0.05 compared to control, based on Student’s t-tests. Note that 
the effect of LPC is probably an artefact as LPC also decreased nonspecific binding, and it was 
without action in peptide binding assays (Figure 25). 
 
4.5.4. SPC, LPC and LPA release Ca2+ from bovine brain microsomes, while 
ryanodine and caffeine do not 
Our data reveal that SPC directly inhibits RyR1. Thus, the question arose, could Ca2+ 
mobilization by SPC from brain microsomes be attributed to RyR activation as suggested 
by Dettbarn et al. [56]? Hence, I studied RyR activity similarly as these authors had, 
isolating microsomes from bovine brain cerebrum by differential centrifugation, loading 
these with Ca2+ in the presence of an ATP-regenerating system, and measuring Ca2+ 
release using a fluorescent Ca2+ indicator. 
I have found that while SPC, LPC and LPA at a concentration of 100 μM each 
mobilized Ca2+, classical channel activators such as 1 μM ryanodine and 5 mM caffeine 
only showed minor effects (Figure 32). S1P could not be tested because of solubility 
difficulties, since for microsomes to remain intact, only gentle suspension could be 
applied, which hindered solubilization of this hydrophobic sphingolipid. Since ryanodine 
is known to act as an activator at lower concentrations and as an inhibitor at higher 
concentrations, I applied ryanodine in the concentration range of 100 nM to 100 μM, to 
rule out the possibility that I am trying to trigger Ca2+ release with an inefficient amount of 
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ryanodine, but significant Ca2+ efflux could not be observed at any concentration. The 
possibility that the membranes lacked functioning proteins can be excluded, since the 
loading of microsomes was an ATP-dependent process. These results suggest that the 
SPC-evoked Ca2+ response of cerebral microsomes could not be solely attributed to RyR 
activation, the majority of the effect was caused by some other mechanism. 
 
 
Figure 32 Ca2+ release measurements on bovine brain microsomes using a Fluo-3 Ca2+ 
indicator. 0.5 mg/ml microsomes were loaded with Ca2+, and release was triggered by the addition 
of either 1 μM ryanodine, 5 mM caffeine, 100 μM SPC, LPC or LPA. The amount of liberated 
Ca2+ was calculated as the percentage of Ca2+ released upon the addition of 2 μM Ca2+ ionophore 
A23187. Each trace is a representative of at least three independent measurements. 
 
4.5.5. SPC does not break the permeability barrier of membrane preparations 
To rule out the possibility that SPC’s action on SR vesicle and microsomal preparations is 
an artefact due to membrane permeabilization, I examined this issue using two 
independent methods. First, I explored the effect of SPC on proteinless liposomes using a 
sedimentation assay. Since these vesicles do not contain ion channels, the release of the 
radioactive Ca2+ entrapped during their formation, could only be the consequence of 
disrupting the integrity of the lipid bilayer. I found that neither 100 μM SPC, LPC or LPA 
liberated significant amounts of Ca2+ from liposomes, while 2 μM Ca2+ ionophore A23187 
and 0.2% saponin detergent released the majority of stored Ca2+ (Figure 33A). In the other 
experimental setup, SR vesicles were loaded with [14C]glucose, and release was 
determined after dilution in an unlabeled medium. These measurements also reassured me 
that the lysophospholipids do not disrupt the permeability barrier at the concentrations 




Figure 33 Membrane permeability assays. (A) Measurement of 45Ca2+ release from proteinless 
liposomes. Liposomes were formed from 1 mM brain total lipid extract (Avanti Polar Lipids, 
131101) in buffer containing 1 mM CaCl2 spiked with 5 μCi/ml Calcium 45 radionuclide. 
Liposomes were washed twice, and after the addition of either 2 μM Ca2+ ionophore A23187, 
0.2% saponin, 100 μM SPC, LPC or LPA, release of Ca2+ was determined by measuring 
radioactivity in both the pellets and the supernatants. Remaining radioactivity in pellets is shown, 
data points depict mean ± S.E. (n=3), asterisks denote significant differences at p<0.05 compared 
to control, based on Student’s t-tests. (B) Measurement of [14C]glucose efflux from skeletal SR 
vesicles. Vesicles were loaded with [14C]glucose and retained radioactivity was measured after 
dilution into unlabeled release medium. 
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5. DISCUSSION 
5.1. Identification of an interaction with potentially important consequences 
in Ca2+ and lipid signaling 
Sphingosylphosphorylcholine (SPC) and sphingosine-1-phosphate (S1P) have emerged in 
the past 20 years as important mediators of cellular signaling. Perhaps the most exciting 
feature of their biology is that they can act as first and second messengers as well. 
Although their action on plasma membrane G protein-coupled receptors is extensively 
studied and quite well elaborated, not much is known about their intracellular site and 
mechanism of action. Initially, my supervisor, Károly Liliom postulated that these 
sphingolipids might interact with calmodulin (CaM). Indeed, several published data point 
to the reasonability of this idea: 1) CaM binds to its target proteins and to its aromatic 
inhibitors through hydrophobic interactions [125], 2) sphingosine has been shown to be an 
inhibitor of several CaM-dependent enzymes [126-128], 3) sphingosine kinase binds to 
and is regulated by CaM [129, 130] and 4) S1P and SPC can mobilize Ca2+ from internal 
stores [50, 51]. 
In the beginning, my goal was to screen S1P, SPC and structurally similar 
glycerolipids lysophosphatidic acid (LPA) and lysophosphatidylcholine (LPC) for a 
specific interaction with CaM. I carried out classical biochemical binding assays using 
purified proteins and lipids, and in vitro enzymatic assays to assess the functional 
consequences of the interaction. This approach was rather new in sphingolipid signaling, 
since most publications in the field present data obtained from live cell experiments, the 
results of which are often hard to reconcile to interactions of individual partners. 
Presumably this is the reason why the intracellular target sites of S1P and SPC are still 
unidentified, and why the field lags behind GPCR research, which is relatively easily 
explored by cell biological methods. In my opinion, to identify the intracellular target 
proteins through which these lipids exert their actions as second messengers, and to 
characterize their interaction without the disturbing effects of other cellular components, 
an approach using purified proteins is more efficient. 
My first set of experiments revealed several important aspects of the CaM-SPC 
interaction. Intrinsic Tyr (Figure 12) and dansyl-labeled protein (Figure 13) fluorescence 
demonstrated that SPC binds selectively to CaM compared to S1P, LPC and LPA. 
Importantly, selectivity has also been demonstrated compared to membrane-composing 
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lipids such as sphingomyelin, phosphatidylcholine, phosphatidylethanolamine, 
phosphatidylserine and phosphatidylinositol (data not shown). Surprisingly, SPC bound 
both in the presence and absence of Ca2+, unlike classical aromatic CaM inhibitors such as 
trifluoperazine, calmidazolium and W-7, which only bind to Ca2+-saturated CaM [82, 
131]. This finding has several interesting structural and functional implications, which I 
focused on in my later work. 
Titration of CaM with SPC resulted in a saturation curve showing strong 
cooperativity and an apparent KD of 46.9 ± 0.8 μM and 21.7 ± 1.3 μM, in case if intrinsic 
Tyr and dansyl fluorescence, respectively. These values lie close to the critical micelle 
concentration (CMC) of the lipid (33 ± 2 μM, Figure 14). These data strongly suggest that 
micelles are necessary for binding, thus, the high SPC concentration is only required for 
the development of the appropriate in vitro conditions for the interaction, i.e. that the 
sphingolipid should be clustered. Once SPC clusters exist, binding occurs, resulting in a 
strong interaction between SPC and CaM, characterized by a submicromolar dissociation 
constant. This mode of binding also raises interesting issues regarding the mechanism of 
binding, addressed later on (Chapter 5.2.). 
I demonstrated that the binding of SPC to CaM has functional effects as well, since 
SPC inhibited the Ca2+-CaM-dependent activity of two target enzymes, calcineurin 
(Figure 15) and phosphodiesterase. Dose response for calcineurin activation by CaM in 
the absence and presence of SPC provided the first clue for competitive inhibition and also 
indicated a strong binding of SPC to CaM. The fact that the synthetic stereoisomer L-
threo-SPC was also active in both the binding and the functional assays implies that CaM 
might indeed be the mediator of SPC’s intracellular actions, since previous studies have 
shown that the effects of extracellularly applied SPC are stereospecific, while those of 
intracellularly applied are not [49, 132]. 
SPC’s selective inhibitory action on CaM unambiguously has important 
implications in cellular signaling. First, it proposes that CaM might be an intracellular 
receptor for SPC, making CaM, the hub of Ca2+ signaling, the first putative intracellular 
target of the sphingolipid. Second, it raises the possibility for a novel endogenous 
regulation of CaM, making SPC the only known small molecule of mammalian cells 
capable of modifying CaM's activity besides Ca2+ ions. 
 
 68 
5.2. Development of a stoichiometry-dependent lipid-protein binding model 
My first set of experiments clearly indicated that the CaM-SPC interaction is worth 
further, more precise analysis. To unravel the structural and mechanistic details of the 
binding process, we (Veronika Harmat, József Kardos, Módos Károly, Tóth Judit and 
myself) utilized several independent biochemical and biophysical methods that allow 
evaluation of distinct features of the lipid-protein interaction. Based on our results we 
propose a complex and consistent model of CaM binding to SPC both in the presence and 
absence of Ca2+. 
 As Ca2+CaM is the functionally more important and better-characterized species, I 
present a detailed model on the Ca2+CaM – SPC interaction (Figure 34). Both ITC (Figure 
18) and stopped-flow (Figure 21) measurements revealed a strong binding of Ca2+CaM to 
SPC (KD of 60 nM and 20 nM, respectively) with a stoichiometry suggesting that the 
protein binds to micelles (values of 100-200 and 114 SPC/Ca2+CaM, respectively). DLS 
measurements (Figure 19) verified this concept as the size of this species was determined 
to be significantly larger than SPC micelles or CaM alone. The driving force of this 
interaction is probably an electrostatic attraction between the positively charged choline 
groups of SPC and the negatively charged residues of CaM. This notion is aided by the 
fact that SPC micelles are supposedly perceived as positively charged spheres with their 
hydrophobic carbon chains buried inside, and also that this phase was shown to be entirely 
enthalpically driven in ITC experiments (Table 5). 
 ITC (Figure 18) and stopped-flow (Figure 21) measurements also demonstrated 
that a second process takes place during binding of Ca2+CaM to SPC micelles, which is 
observable when micelles become limiting. This second process results in a complex with 
an estimated stoichiometry of 3-7 SPC monomers/protein. As our crystal structure of the 
Ca2+CaM/SPC complex (Figure 16) revealed that Ca2+CaM can adopt a collapsed 
conformation wrapped around a few SPC molecules (4 in our structure), we hypothesized 
that the species resulting from the second process is identical to the one we see in the 
crystal structure. This concept was supported by DLS experiments (Figure 19) since the 
size of this species was significantly smaller than micelles or the protein alone. 
Furthermore, fluorescence measurements with ANS (Figure 20) clearly demonstrated that 
micelles are disrupted during the second process. This species strikingly resembles the 
collapsed conformation of CaM, which the protein adopts upon binding to target peptides 
or synthetic inhibitors (Figure 17). Intriguingly, the peptide binding site of CaM is now 
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occupied by several lipid molecules. Since the exact positions of the SPC headgroups were 
ambiguous to some extent in the crystal structure, hydrophobic interactions between the 
aliphatic chain of the lipid and the hydrophobic residues of the protein are more likely to 
contribute to the stabilization of this complex. 
 
 
Figure 34 Stoichiometry-dependent binding model for the Ca2+CaM – SPC interaction. The 
SPC micelle is represented as a sphere with a radius of 30 Å. Molecular surfaces are colored 
according to surface charge distribution (red: negative, blue: positive). First process (step 1 and 2): 
Ca2+CaM molecules bind to the positively charged micelle. Electrostatic interaction with the acidic 
CaM regions is important in this phase. Second process (step 3): Saturation of the micelle surface 
with protein molecules will eventually result in the disintegration of the micelle and Ca2+CaM 
adopting a collapsed conformation (transparent view) embracing several SPC monomers (grey). In 
this phase hydrophobic interactions play an important role in complex formation. The exact 
mechanism by which the protein disintegrates the micelle is unknown, as depicted by the dashed 
arrow. Crystal structures of Ca2+CaM (PDB structure 1UP5) and Ca2+CaM/SPC (PDB structure 
3IF7) were used for modeling the complexes. Note that while the Ca2+CaM – SPC micelle 
complex is only a model, the structure of the resulting Ca2+CaM/SPC complex has been 
determined by X-ray crystallography. The figure was prepared using Pymol (DeLano Sci.). 
 
 We envision that the surface of SPC micelles are coated by CaM, until there is not 
enough free space for the negatively charged protein to bind to the positive surface 
provided by the choline headgroups of SPC without sterically hindering each other (Figure 
34). As micelles are dynamic structures, we propose that they fluctuate during the 
competition of CaM molecules for their positive surface, which leads to the appearance of 
the collapsed protein conformation engulfing several lipid monomers. CaM molecules 
embracing several SPC monomers continuously leave the micelle-protein complex, thus 
gradually resulting in disintegration of the micelle. It is important to emphasize that this 
scenario only pictures one possible way the two species (CaM bound to micelles and the 
collapsed conformation) might arise, other possibilities also exist. What we have 
demonstrated unambiguously is the stoichiometry-dependent appearence of the two 
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species, both of which are inhibitory. The lipid shields the target peptide binding sites in 
both CaM conformations resulting in an inhibitory effect in enzyme activity (Figure 15) 
and peptide-binding assays (Figure 25). 
 The binding of apoCaM resembles that of Ca2+CaM, as it can be described by 
similar two processes, but with a difference in the complex arising in the second phase. 
The apoCaM-SPC complex can be characterized by a stoichiometry of approximately 40 
SPC monomers / protein and is larger than the one appearing in the presence of Ca2+. 
Presumably, this phenomenon can be explained by the fact that apoCaM is unable to adopt 
a collapsed conformation with a hydrophobic binding channel surrounded by acidic 
residues as Ca2+CaM can. As mentioned earlier, the fact that SPC can bind to apoCaM is a 
unique feature among CaM antagonists. This special behavior might be explained by the 
fact that the binding of the protein to the micelle is almost entirely driven by electrostatic 
forces, as the hydrophobic chains of the lipid are buried within the micelle. Hence, the 
open hydrophobic patches of the protein are not required in the initial stage of binding. In 
contrast, traditional aromatic inhibitors bind as monomers, offering mostly the possibility 
of hydrophobic interactions with CaM. 
 It is important to note that the precise affinity and stoichiometry values determined 
here characterize the protein-micelle system and should not be directly applied to cellular 
conditions. What our model reveals about the in vivo lipid-protein interaction is the 
following: 1) CaM interacts with SPC clusters at high (nanomolar) affinity; 2) once the 
SPC-CaM complex forms, it can adopt different conformations depending on several 
factors, most likely on the curvature and size of the lipid cluster and the local abundance 
of CaM. For a more particular consideration of the physiological relevance and the in vivo 
plausibility of the interaction see Chapter 5.6. 
 
5.3. Kinetic description of CaM inhibition by SPC 
After we understood the details of how SPC binds to CaM, I thought it highly important to 
reveal how exactly this affects target recognition by CaM. To decipher the mechanism of 
this novel regulation of CaM by SPC, we (Judit Tóth and myself) turned to the simplest 
model system for CaM-target interactions, and studied the impact of SPC on the 
interaction between CaM and its target peptides using fluorescence methods. 
Having recognized that relevant kinetics data are missing on the mechanism of 
CaM binding to its target peptides, we first aimed to characterize the CaM-melittin 
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interaction at saturating Ca2+ concentrations (Figure 22). Details of the model we 
established are shown in Scheme 1 and in Figure 35, and its main features are 1) rapid, 
reversible binding of the peptide to CaM accompanied by a fluorescence increase of the 
dansyl label, 2) slower, reversible conformational change with further apparent 
fluorescence increase. The overall process is shifted to the right implying that the 
predominant conformation is the compact dCaM.ME** species. Our two-step sequential 
binding model agrees with literature data proposing that an initial binding of target 
proteins occurs on the N-terminal domain of CaM followed by the formation of the 
compact structure shown in Figure 35 [120]. 
 
Figure 35 Shematic representation of the model by which SPC competes for CaM with target 
peptides. PDB IDs 1CLL and 1CDM were used to prepare the structures representing CaM and 
the CaM.peptide** complex, respectively. The CaM (blue) and the peptide (magenta) molecules 
are shown as cartoons. Bound Ca2+ ions are shown as light blue spheres. The CaM.peptide* and 
the CaM.SPC species are purely hypothetical, and are depicted by the Ca2+-saturated CaM 
structure 1CLL bound to the peptide or the micelle. The SPC micelle is depicted as a grey sphere 
with a diameter comparable to the width of a lipid bilayer. Rate constants shown in brackets are 




We demonstrated that SPC competes for CaM with the model CaM-binding 
domain melittin, using ligand chasing experiments for both ligands (Figures 23-24). The 
kinetic parameters we obtained in the SPC chasing assay (Figure 23) clearly indicated that 
SPC competes with melittin for the same binding site. SPC could only bind to CaM upon 
melittin dissociation as its binding rate constant was limited by the dissociation rate 
constant of the CaM-melittin complex (Table 6). No sign of a trimeric complex 
comprising all three interacting partners have been observed. The previous observation 
that SPC binds to CaM as a micelle, not as a monomer, was reinforced in the stopped-flow 
measurements as well. 
The reverse chasing experiment, in which melittin served as a competitor of the 
pre-bound SPC (Figure 24), also indicated the concentration dependent replacement of the 
pre-bound ligand for melittin on CaM. In addition, this experiment yielded information 
relevant to the size of the SPC micelle that interacts with CaM. Using the relation 
described in Eq. 3 and kinetic simulations, we can estimate that an SPC micelle is 
composed of about 150 monomers. 
Please note that all stopped-flow experiments were carried out with protein-lipid 
ratios allowing only CaM binding to micelles, but not the generation of the collapsed 
protein conformation. Therefore, under these experimental conditions only binding to 
micelles was investigated, and as such, only the micelle-bound form is depicted in Figure 
35. 
 
5.4. CaM as the intracellular receptor for SPC? 
With experiments discussed in Chapters 5.1-5.3, we laid down the structural and 
mechanistic basis of CaM inhibition by SPC. I reckoned that the most important following 
step is to reveal what the functional consequences of such a novel regulation could be in 
the context of a cellular environment. My approach was to make a connection between the 
literature on SPC’s actions as a second messenger and CaM. This proved to be a relatively 
easy task, since the most well-described intracellular effect of SPC is mobilization of Ca2+ 
[50, 51], and CaM has been shown to play a role in the negative feedback of the Ca2+ 
signal [58, 75, 76]. My hypothesis was that SPC elevates intracellular Ca2+ levels by 
interfering with this negative feedback. 
Several published data suggested that SPC is involved in the regulation of 
ryanodine receptors (RyRs) [40, 56, 61], hence, I started working on the CaM-binding 
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domain of the skeletal muscle Ca2+ release channel (RyR1). Moreover, Ca2+ binding to 
CaM leads to an N-terminal shift in its binding site on RyR1 [98], thus, this CaM-binding 
domain binds CaM constitutively regardless of Ca2+, providing a convenient tool to study 
the effect of SPC on the apoCaM-target interaction as well. I clearly demonstrated that 
SPC dissociates the complex between Ca2+-saturated CaM and the CaM-binding domain 
of RyR1 (Figure 25). This effect was selective compared to structurally related signaling 
lipids such as S1P, LPC and LPA, and occured with an EC50 of approximately 20 μM. 
This is in the similar low micromolar range as the observed Ca2+ mobilizing action of SPC 
in former reports [40, 49, 50, 56]. Furthermore, it has also been shown that L-threo-SPC, a 
synthetic stereoisomer, liberated Ca2+ only if administered intracellullarly, while was 
ineffective extracellularly [49, 132]. The fact that in my measurements L-threo-SPC gave 
similar results as the naturally occuring D-erythro-SPC, also implies that the effect we 
observe and the findings by these authors may share a common underlying mechanism. 
I also showed that SPC dissociates the complex between apoCaM and the CaM-
binding domain of RyR1 (Figure 26). This finding suggests an entirely novel endogenous 
regulation for RyRs and other proteins that constitutively bind CaM regardless of Ca2+, or 
are regulated by CaM in any other unconventional way (Figure 11). SPC is the first 
compound having the potential to completely free these proteins from the Ca2+ sensor. 
Regarding other proteins involved in Ca2+ homeostasis, Ca2+CaM has been shown 
to inhibit the two most abundant Ca2+ channels, RyRs and IP3Rs [58], and to activate the 
plasma membrane Ca2+ pump (PMCA) [133]. Once again, according to my hypothesis, if 
SPC interferes with any of these interactions, that would activate the Ca2+ channels and 
inhibit the Ca2+ pumps, eventually leading to the elevation of intracellullar Ca2+ levels. I 
demostrated that SPC disrupts the complex between CaM and the CaM-binding domain of 
RyR1, IP3R1 and PMCA (Figure 27). I excluded Ca
2+ pumps of the endoplasmic 
reticulum (SERCAs) from my study because they are not directly regulated by CaM. 
Experiments carried out with micelles containing other lipids besides SPC (Figure 28) 
confirmed that SPC can displace CaM from its targets even when incorporated into a 
mixed lipid environment. This finding argues for the plausibility of the same phenomenon 
to occur under in vivo conditions near a membrane surface enriched in SPC (for a more 
thorough discussion refer to Chapter 5.6.). Therefore, my findings provide a putative 
explanation for the Ca2+ mobilizing activity of SPC. Of course the interactions the 
sphingolipid can actually modify in vivo are probably selected by their cellular 
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localization, and the concept needs to be tested on intact proteins (see Chapter 5.5.) and 
cellular systems. 
5.5. Regulation of RyRs by SPC – a short detour 
Following the previous line of thought, but moving on to intact proteins, I started working 
with RyRs. My attempts to purify active receptors were rather unsuccessful, and I realized 
that working with these huge channel complexes requires expertise, which we lacked in 
our laboratory. To overcome this problem, I contacted Dr. Gerhard Meissner at the 
University of North Carolina, who has been conducting exactly those types of 
experiments, studying RyR regulation by CaM, that I wished to repeat, but focusing on the 
effect of SPC. He was enthusiastic about the project and invited me in his laboratory, 
which I joined as an EMBO Short-term Fellow for two months. 
As presented in the Introduction (Chapter 1.4.), literature on regulation of RyRs by 
SPC is quite contradictory. One group of investigators reported an activation of these 
receptors by the sphingolipid [40, 56], while another one observed channel inhibition [61, 
62]. Neither group examined the role of CaM in this process, and I expected to see that 
SPC, by dissociating CaM from the RyR1, relieves negative feedback inhibition of 
Ca2+CaM, leading to channel opening. 
I showed that SPC indeed displaces CaM from the intact channel (Figure 31). The 
functional consequences of CaM dissociation were explored in single channel 
measurements and a ligand ([3H]ryanodine) binding assay. Single channel recordings on 
purified RyR1 (Figure 29) revealed that SPC at concentrations well below its CMC 
decreases the open channel probability of RyRs, and induces the appearance of long-lived 
closed states. These data are in good agreement with former reports that low 
concentrations of SPC decrease the open probability of the cardiac ryanodine receptor 
(RyR2), and RyR2 inhibition is characterized by the appearance of long-lived closed 
channel states [61, 62]. As expected, this inhibitory effect was independent of CaM, since 
we were only able to study the effects of monomeric SPC in single channel measurements, 
because SPC concentrations greater than 10 M resulted in disruption of the sensitive 
reconstituted bilayer. 
 To overcome this limitation, [3H]ryanodine binding experiments were carried out 
(Figure 30), which confirmed inhibition of receptor activity in the absence of CaM. 
However, if Ca2+CaM was present, this inhibition could not be observed. This 
phenomenon could be explained by assuming that two antagonistic molecular events are 
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occurring at the same time: 1) a direct inhibition of channel activity by the sphingolipid, as 
suggested by single channel recordings and 2) displacement of inhibitory Ca2+CaM by 
SPC, as suggested by [35S]CaM binding assays. 
 Taken together, our data are consistent with the findings of Uehara et al. [61, 62] 
in that SPC directly inhibits RyRs. Our current results are also consistent with our former 
data suggesting that SPC can dissociate the complex between RyRs and CaM, and we 
have found that the presence of CaM can modify the direct inhibitory effect of SPC on the 
channel. However, under our experimental conditions, channel activation was never 
observed, whereas an involvement of ryanodine receptors in SPC-induced Ca2+ release 
from brain microsomes has been reported [56]. One possibility was that brain expresses all 
three mammalian RyR isoforms [134] and therefore type 3 RyR was responsible for the 
activating effects. Under similar experimental conditions, we found that while 100 μM 
SPC, LPC and LPA each released a large amount of Ca2+ from brain microsomes, classical 
channel activators that act on all three RyR isoforms such as 1 μM ryanodine and 5 mM 
caffeine only had minor effects (Figure 32). Interestingly, Dettbarn et al. were also 
incapable of triggering Ca2+ release by ryanodine or caffeine. Their major argument for 
SPC's action on RyRs was that ruthenium red, an inhibitor of the RyRs, inhibited SPC-
elicited Ca2+ release. However, in two subsequent studies, SPC-induced Ca2+ release was 
much less sensitive to ruthenium red inhibition [40, 57]. Taken together, the sphingolipid's 
mechanism of action on cerebral microsomes remains elusive, but a significant 
contribution of RyRs to the phenomenon can most likely be excluded. 
 In conclusion, we have shown that SPC regulates RyR1 in a diverse manner. 
Below the CMC, SPC directly inhibits the skeletal muscle Ca2+ release channel, while 
above the CMC, besides a direct action on the channel, the sphingolipid also displaces 
inhibitory Ca2+CaM from the RyR1, further modifying channel activity. However, net 
activation of the channel never occurs, so SPC’s effect on the RyR cannot explain how the 
sphingolipid liberates Ca2+ from the endoplasmic reticulum. Although this question 
remains open, we have at least clarified the role of SPC in RyR regulation. 
All available information in the literature clearly pointed to RyRs as the link 
between CaM and SPC-elicited Ca2+-release. Unfortunately, it turned out that some of 
these data are not well established, and instead of activating these receptors, SPC directly 
inhibits channel opening. Nevertheless, we should keep in mind that even though RyRs 
proved to be a bad choice of study, CaM inhibition by SPC can still be the key to the 
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sphingolipid’s second messenger function, exerting its effects on some other Ca2+ channel 
or pump. 
 
5.6. Considerations on the physiological relevance of the CaM-SPC 
interaction 
During my PhD studies I presented my work at several scientific forums, and it was 
always greeted with much enthusiasm, but one controversial issue always emerged. What 
is the physiological relevance of our findings if micelles are required for binding? To 
avoid possible misunderstandings, I decided to dedicate a chapter to my arguments on this 
subject. Of course, I do not think that an in vivo interaction would occur between a protein 
and micelles, as micelles do not exist in living cells. I opine that a membrane surface 
enriched in SPC might serve as an in vivo equivalent for the SPC surface presented by 
micelles in vitro. My detailed reasoning is as follows. 
It is very important to distinguish between our in vitro experimental conditions and 
the situation in a cellular environment. We use micelles as the simplest alternative to 
model a clustered SPC environment. We worked with high SPC and CaM concentrations 
to 1) obtain stable micelles and 2) to obtain large heat effects, DLS signals, crystals etc. In 
vivo, such elevated concentrations of either interacting partner are unnecessary, only a 
clustered form of SPC is required, already given in a membrane environment. Our 
simplified artificial micelle system was very useful to reveal the molecular events of 
binding and to extract precise Kd and stoichiometry values. Nevertheless, we should 
always keep in mind that the binding parameters obtained this manner cannot always be 
applied directly to the cellular conditions. For example, the first binding process, when 
SPC binds to intact micelles yielded a stoichiometry of ~100-200 SPC molecule/CaM. 
This large number arises from the fact that a micelle consists of ~100-200 monomers. 
Thus, if the interacting partner is smaller, for example a membrane surface containing 10-
20 SPC molecules, the stoichiometry value would be accordingly lower. 
Therefore, the exact affinity and stoichiometry values characterize the in vitro 
protein-micelle system and should not be directly applied to the in vivo situation. Yet, this 
study provides important conclusions about the physiologic lipid-protein interaction as 
well. These are the following: 1) CaM interacts with SPC clusters at high (nanomolar) 
affinity; 2) once the SPC-CaM complex forms, it can adopt different conformations 
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depending on several factors, most likely on the curvature and size of the lipid cluster and 
the local abundance of CaM. 
We have demonstrated that the interaction can manifest itself in both mixed lipid 
(liposomes [110], mixed micelles (Figure 28 and [96])) and protein (measurements on 
cerebral microsomes [111]) environments, which findings argue for the plausibility of the 
same phenomenon to occur under in vivo conditions near a membrane surface enriched in 
SPC. Of course, the ultimate goal would be to provide in vivo evidence for the CaM-SPC 
interaction. Unfortunately, little is known about the metabolic pathway that generates SPC 
(refer to section 1.3), which hinders our ability to design and conduct relevant 
experiments. Simply treating cells with SPC would be largely ineffective, as the 
membrane permeability of SPC is very restricted. Regarding the estimated cellular 
concentrations of SPC, albeit information is yet scarce, its presence has been demonstrated 
under several physiologic and pathologic conditions. SPC accumulates in Niemann–Pick 
disease [41] and atopic dermatitis [42], and Betto et al. [40] measured the overall SPC 
concentration in cardiac muscle to be approximately 15.6 M, which is very promising. A 
lot of future work in Károly Liliom’s laboratory will be focused on finding the SPC 
producing enzyme, which in my opinion would be absolutely necessary to study the CaM-
SPC interaction in vivo. 
 
5.7. Major conclusions and significance of the findings 
In this report I demonstrate that the putative second messenger SPC, binds to the 
ubiquitous Ca2+ sensor CaM selectively compared to related lysophospholipid mediators 
such as S1P, LPC and LPA. The interaction has functional effects, as the sphingolipid 
inhibits the CaM-dependent activity of target enzymes calcineurin and phosphodiesterase. 
Unlike classical aromatic CaM antagonists, SPC is a natural compound and binds 
regardless of the presence of Ca2+. Furthermore, I present a crystal structure of the 
Ca2+CaM/SPC complex, and a stoichiometry-dependent lipid-protein binding model. At 
low protein-to-lipid ratios CaM binds to intact micelles, whereas at high protein-to-lipid 
ratios micelles are disintegrated by the protein, eventuating in a compact globular 
conformation of Ca2+CaM. I provide kinetic evidence for a competitive inhibitory 
mechanism and show that SPC disrupts the complex between CaM and the CaM-binding 
domain of several proteins involved in Ca2+ homeostasis, suggesting a mechanism by 
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which SPC can evoke a Ca2+ response and exert its second messenger functions. In the 
end, I clarify the controversial role of SPC in RyR regulation and the role of CaM in it. 
I believe that results presented in this thesis are new and significant findings for 
three main reasons. First, the identification of SPC as a CaM inhibitor is the first specific 
suggestion of the sphingolipid’s intracellular target site, and provides a link between the 
sphingolipid and Ca2+ signaling. Second, inhibition of CaM action by SPC proposes an 
utterly new type of endogenous regulation for the Ca2+ sensor. So far, no other second 
messenger has been suggested to regulate CaM function, apart from Ca2+ ions. Moreover, 
SPC can bind to both the Ca2+-bound and free forms of the protein, offering multiple non-
conventional ways of modulating CaM activity. Finally, the two-step binding model 
presented here describes a novel and peculiar biochemical mechanism, which might be 
applicable to other lipid-protein interactions as well, and reveals how versatile such 




Sphingosine 1 phosphate (S1P) and sphingosylphosphorylcholine (SPC) are important 
mediators of cell signaling, possessing the unique feature to act as first and second 
messengers as well. Although their activation of cell surface G protein-coupled receptors 
has been studied extensively, their intracellular sites of action are yet to be identified. We 
hypothesized that these sphingolipids might bind to calmodulin (CaM), the ubiquitous 
intracellular Ca2+ sensor of eukaryotes. 
In my thesis I demonstrate that 1) SPC binds to both apo- and Ca2+-bound CaM 
selectively, when compared with the related lysophospholipid mediators S1P, LPA 
(lysophosphatidic acid) and LPC (lysophosphatidylcholine). Binding has serious 
functional consequences, as SPC inhibits the Ca2+CaM-dependent activity of target 
enzymes calcineurin and phosphodiesterase. 2) I present a 1.6 Å resolution crystal 
structure of the CaM-SPC complex, in which the sphingolipid occupies the conventional 
hydrophobic binding site on CaM. Based on thermodynamic and kinetic studies I describe 
a peculiar stoichiometry-dependent binding process: at low or high protein-to-lipid ratio 
CaM binds lipid micelles or a few lipid molecules in a compact globular conformation, 
respectively. 3) I give mechanistic insight into CaM inhibition by SPC based on 
fluorescence stopped-flow studies, and present experimental evidence that both species 
compete for the same target site on CaM. 4) I show that SPC disrupts the complex of CaM 
and the CaM-binding domain of RyR1, IP3R1 and the PMCA. Interfering with these 
interactions, and inhibiting the negative feedback CaM has on Ca2+ signaling, could lead 
to intracellular Ca2+ mobilization, providing a means by which the sphingolipid exerts its 
second messenger functions. 5) Finally, utilizing single channel measurements and 
radioactive binding assays, I demonstrate that SPC regulates the intact ryanodine receptor 
(RyR) by both CaM-dependent and -independent mechanisms. 
I believe that these findings are a major contribution to both the Ca2+ and the lipid 
signaling field. We propose that CaM might be the intracellular target site for SPC and 
also raise the possibility of a novel endogenous regulation of the well known Ca2+ sensor. 
Furthermore, our detailed structural and mechanistic characterization of the CaM-SPC 
complex might provide insight into other lipid-protein interactions as well, an emerging 




A szfingozin-1-foszfát (S1P) és a szfingozilfoszforilkolin (SPC) lipid mediátorok összetett 
szerepet töltenek be a jelátvitelben, különleges tulajdonságuk, hogy ugyanazok a 
molekulák els dleges és másodlagos hírviv k is lehetnek. Míg sejtfelszíni G-fehérje 
kapcsolt receptoraik azonosítottak és jól jellemzettek, addig nem sokat tudunk 
intracelluláris célfehérjéikr l. Szakirodalmi adatok alapján feltételeztük, hogy ezek a 
lipidek kölcsönhatnak a kalmodulinnal (CaM), a legáltalánosabb intracelluláris kalcium 
szenzorral. 
A jelen dolgozatban ismertetem eredményeim, mi szerint 1) az SPC szelektíven 
köt dik mind az apo mind a Ca2+-mal telített CaM-hoz, míg a szerkezetileg hasonló 
lizofoszfolipidek mint az S1P, LPC (lizofoszfatidilkolin) és LPA (lizofoszfatidsav) nem. 
A kölcsönhatásnak komoly funkcionális következményei vannak, hiszen az SPC 
specifikusan gátolja mind a foszfodiészteráz mind a kalcineurin célenzimek CaM-függ  
aktivitását. 2) Bemutatom a CaM-SPC komplex 1.6 Å felbontású röntgenszerkezetét, 
amelyben a fehérje a CaM-célpeptid komplexekre jellemz  zárt konformációt veszi fel, és 
négy sphingolipid molekula foglalja el a fehérje hidrofób köt csatornáját. Ismertetek egy 
termodinamikai és kinetikai mérések alapján felállított olyan újszer  lipid-fehérje köt dési 
modellt, amelyben a CaM alacsony fehérje-lipid aránynál a micellákhoz köt dik, míg 
magas fehérje-lipid aránynál magába zár néhány SPC molekulát. 3) Tranziens kinetikai 
bizonyítékkal szolgálok arra nézve, hogy a peptid és a szfingolipid ugyanazért a 
köt helyért verseng a CaM-on. 4) Bemutatom, hogy az SPC disszociáltatja a CaM és 
számos Ca2+ homeosztázisban szerepet játszó fehérje (IP3R, RyR, PMCA) CaM-köt  
doménje közötti komplexet, amely magyarázatul szolgálhat az SPC sejten belüli Ca2+ 
mobilizáló hatására. 5) Végül ismertetem ryanodine receptorokon (RyR) kapott 
eredményeimet, melyek alapján a szfingolipid mind CaM-függ  mind CaM-független 
módon szabályozza a Ca2+ csatornát. 
Hiszem, hogy az itt bemutatott eredmények jelent sen hozzájárulnak mind a Ca2+ 
mind a lipid jelátvitel témakörében felgyülemlett ismeretekhez. Felvetjük a lehet ségét a 
CaM egy biológiailag releváns, újszer  szabályozásának, és javaslatot teszünk az SPC els  
intracelluláris receptorára. Továbbá felállítottunk egy olyan kétlépcs s, szerkezeti-
biofizikai lipid-fehérje köt dési modellt, mely feltételezhet en más kölcsönhatásokra is 
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